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Abstract: 
Introduction: The gold standard reconstruction for facial reanimation is the functional muscle 
transfer. The reinnervation of a muscle is never complete and clinical results are variable with 
20% not achieving a satisfactory outcome (1). This study uses transgenic YFP mice to 
investigate the patterns of reinnervation through a nerve repair and a nerve graft. 
 Method: 81 YFP-16 mice were studied in three intervention groups (nerve repair, nerve graft 
and nerve cut) over three time periods (four, six and twelve weeks post intervention). Two 
parameters were investigated: the number and surface area of reinnervated neuromuscular 
junctions and the number and calibre of regenerating axons. An assessment was made of motor 
unit proportions. 14 YFP-H mice were used to further investigate the patterns of axon 
regeneration through a nerve repair and graft. 
Results: In the nerve cut group there was no reinnervation of the muscle at any time period. In all 
cases of nerve repair and nerve graft the muscles were completely reinnervated by regenerating 
axons with no significant difference between either intervention group and controls. The number 
and calibre of the regenerating axons was significantly different to controls for both intervention 
groups. The motor units were smaller in both intervention groups, but when the axons were 
thresholded to within two standard deviations of the control axon populations, the motor units 
were larger. 
Discussion: Reinnervation after nerve repair or graft appeared adequate, however the 
neuromuscular junctions showed some evidence of morphological change that persisted. The 
number and type of axons after repair or graft differed from the control groups. There were more 
small calibre axons, suggesting the arbor had been reinnervated by a smaller number of axons 
that branched to increase their influence. These axons showed evidence of remodeling in the 
repair group, but not in the graft group. 
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1.  Introduction 
 
In 2008 I was presenting a clinical poster on reconstructive options in Möebius syndrome at 
the annual meeting of the American Association of Plastic Surgeons in Boston, 
Massachusetts. The keynote speaker at the meeting was a neuroscientist called Jeff 
Lichtman who presented his work on the nervous system using transgenic animals 
expressing Green Fluoroescent Protein. It was a before-and-after moment for me, and I 
knew that I wanted to exploit this tool to help me understand the biology behind the 
clinical applications of nerve regeneration in facial palsy reconstruction. I pestered Jeff for 
nearly two years until he agreed for me to join him in his laboratory in Harvard. The work 
set out in this thesis represents that journey. After a brief training in animal husbandry, 
laboratory experimentation and the theory and use of the confocal and two photon 
microscopes I set off. All the experiments, data collection and analysis presented here were 
performed by me at Jeff Lichtman’s laboratory in Harvard University. The contemplation 
and write up were done back in London with the support of my supervisors. The results 
have been presented at several international meetings of both the plastic surgical and 
neuroscience communities. Papers are in preparation for submission to the plastic surgical 
literature. 
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The near infinite complexity of the human smile has challenged artists and physicians for 
centuries. There are over twenty paired muscles in the head and neck innervated by the facial 
nerve, and most of them are involved in enabling us to smile. A smile can be voluntary or 
spontaneous, or a combination of both. It encompasses the mouth but also the eyes and even the 
nostrils in a way that is unique in every individual. When this system fails to function it is 
usually due to a problem with the facial nerve. Evidence of facial palsy can be seen from over 
four thousand years ago in Egyptian statues. Today facial palsy has an estimated incidence of 50 
per 100,000 population per year (6,7). Schaitkin identified over a hundred possible aetiologies 
from causes as varied as leprosy and Lyme’s disease to injury or surgical trauma. 13% of cases 
are associated with a significant, treatable or life-threatening disorder  (8). Two thirds of cases 
are of unknown cause and as such classified as Bell’s palsy, a diagnosis of exclusion (6,9). 
Freidrich’s original description in the 18th Century attributed this to “rheumatism” (10). For a 
while in the 1930s Bell’s palsy was thought to be caused by oedema of the nerve in its narrow 
intracranial course, leading to a brief vogue for surgical decompression of the bony canal 
(11,12).  Bell’s palsy is probably associated with a viral infection, most likely herpes simplex 
(HSV-1) though this has not been definitively confirmed to date (13-15). Whatever the cause 
facial palsy has a tremendous impact on a person’s life. The American Medical Association 
Guide to the Evaluation of Permanent Impairment rates disabilities according to their 
“percentage whole body impairment”. A unilateral facial palsy scores 10-15% and a bilateral 
facial palsy 30-45% (16). The loss of an index finger by comparison scores 18%. This reflects 
the devastating impact of a seventh nerve palsy, which results in a raft of both functional and 
aesthetic problems. Depending on the degree of sub-branch involvement there can be loss of 
facial expression, oral and ocular incontinence, difficulty with eating and drinking, poverty of 
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articulation and social interaction. The inability to close the mouth adequately results in drooling 
and ultimately dental caries. Similarly, poor eye closure can result in dysfunctional eye 
lubrication and toilet, leading to corneal ulcers and permanent reduction in visual acuity. The 
impact on social participation makes patients shy and unwilling to communicate. In children this 
is detrimental to their development and often contributes to bullying and introversion. A 
unilateral paralysis creates an asymmetry, and a bilateral paralysis leads to an expressionless 
face. 
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1.1 The facial nerve 
Part of what makes the treatment of facial palsy fascinating is the complexity of the facial nerve 
itself (Fig 1). It is the seventh of twelve cranial nerves and was first described in an account 
given by Sir Charles Bell to the Royal Society in 1821 (17). The facial nerve nucleus is one of 
the largest motor cranial nuclei with 7,000-10,500 cells spatially divided into groups that 
correspond to individual mimetic muscles of expression in the face (18-20). Closely associated 
with the facial nerve is another nerve, the intermediate nerve, which carries visceral and somatic 
afferent fibres as well as general visceral efferent fibres. The intermediate nerve is also referred 
to as the sensory component of the facial nerve. The two are so intertwined that they can almost 
be considered as a single entity and this has implications for how we consider the nerve in 
clinical scenarios. 
The motor element arises from the pons and has a tortuous intracranial course, joining the 
intermediate nerve at the internal auditory meatus of the ear canal. Halfway along this canal, 
after a small branch is given off to the stapedius muscle of the inner ear, the facial and 
intermediate nerves divert to exit the skull through the stylomastoid foramen via the facial canal. 
Extracranially, small branches are given off to supply the stylohyoid and digastric muscles in the 
neck, and the posterior auricular muscle behind the ear.  The nerve then passes into the parotid 
gland. It is the only nerve in the human body to pass through the substance of a gland. Within the 
parotid the facial nerve divides into its five main branches to supply the mimetic muscles of the 
face: temporal, zygomatic, buccal, marginal mandibular and cervical (21). 
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The particular dominance of the oral and ocular musculature in man is reflected in the high 
degree of differentiation between the areas that control these muscles in the motor nucleus. Most 
of the facial nerve motor axons are large, 7-10µm in diameter, and the motor units are small, in 
keeping with the high degree of subtlety in their movements (22). Feinstein estimated the human 
platysma to have approximately 25 muscle fibres per axon (23). What is unusual is the relative 
paucity of muscle spindles found in the muscles innervated by the facial nerve. Given the 
precision with which the facial muscles are utilized it might be expected that they would be more 
heavily populated by these proprioceptors that govern muscle tension and tone. Voss found only 
six in a human stylohyoid muscle and Bruesch identified only 140 afferent fibres in the facial 
nerve branches of the cat (24,25). However, even when the trigeminal nerve, which provides 
sensation to the skin of the face, is anaesthetised, proprioceptive signals are preserved (26,27). 
The cell bodies of the intermediate nerve reside in the geniculate ganglion. It has some general 
visceral efferent fibres that stimulate a number of glands in the face (lacrimal, submaxillary, 
sublingual). There are also small, mainly myelinated sensory nerves. Most of these are gustatory 
afferents that are distributed to the tongue and mucosa of the oral cavity via the greater petrosal 
(33-35%) and chorda tympani (45-55%) nerves. However 12-15% of the fibres continue within 
the facial nerve to innervate an area of skin behind the ear (28,29). There is a similar sensory 
cutaneous branch of the facial nerve in man which probably tracks to the trigeminal nuclei (30-
35). Likewise, though most facial reflexes probably rely on afferents in the trigeminal nerve, 
there is some involvement of afferent fibres travelling in the facial nerve (21,36). The facial 
nerve is often thought of as purely motor to the mimetic muscles of the face. In fact it is a much 
more complicated nerve. It has a mixture of myelinated axons that are mainly motor though there 
are some sensory cutaneous and muscle afferent fibres (21). 
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Figure 1. 
Anatomy of the facial nerve 
 
 	
Anatomical representation of the course facial and intermediate nerves in humans (2) 
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1.2 Facial Palsy 
Facial palsy can be classified in several ways. It can be complete or partial depending on how 
many of the muscles of the face are involved. It can also be unilateral or bilateral depending on 
whether one or both sides of the face are paralysed. Bilateral cases are rarer and more often 
congenital, where they are frequently associated with other defects (37). It is possible to have an 
acquired bilateral case in adulthood (38). Given that Bell’s palsy is the commonest cause of 
paralysis it is perhaps reassuring that all Bell’s palsies recover some movement, with 71% 
regaining full movement. In those with some residual paralysis the deficit correlates well with 
both the initial degree of paralysis (partial or complete) and the speed of recovery over the first 
weeks and months after onset. Patients with abnormal movement after six months are unlikely to 
make a full recovery (8,39). 
If the palsy has been caused by division of the nerve as a result of surgery or trauma it is 
recommended to repair the nerve immediately if possible, or within thirty days if there is 
contamination that requires debridement. If there is a nerve gap, from tumour excision or 
debridement, repair with a nerve graft (eg. sural nerve harvested from the same individual) is 
preferable to a nerve repair under tension. If the injury occurs proximal to where the facial nerve 
has subdivided into its main branches in the cheek there is a higher incidence of synkinesis  (40). 
It is thought this occurs due to individual axons entering more than one terminal branch and 
abnormally innervating multiple muscles. Synkinesis results in uncoordinated movements in 
areas of the face that would normally be isolated from one another. If an urgent progressive 
cause of the palsy has been ruled out the initial clinical management is supportive and 
prophylactic. It focuses on measures to reduce the incidence of permanent sequelae. Most 
patients will recover some, if not all, movement and any return of natural expression is generally 
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more aesthetically pleasing than a reconstruction. Most surgeons would not consider intervening 
until at least twelve to eighteen months after there has been no further improvement in function 
(41). If there is residual deficit, facial reanimation can be considered.  
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1.3 Facial reanimation 
Functional muscle transfers were first described in 1970 when Tamai transplanted the biceps 
brachii and rectus femoris muscles from one leg to the other in a dog model and repaired the 
motor nerve (42). It was reliant on two advances that created the modern specialty of 
microsurgery: a better understanding of the blood supply to muscles, bone and skin that allows 
parts of the anatomy be removed and reconnected elsewhere, and the development of the 
instruments and techniques that facilitate operating under a microscope (43-45). Adding muscle 
functionality to the already burgeoning field of microsurgery opened up a new rung on the 
reconstructive ladder. Free functioning muscle transfers are now the gold-standard for facial 
reanimation and can also be used in some extremity reconstructions (46-53). A muscle is 
harvested along with its blood supply and nerve so that it can be transferred en bloc to a new 
location where it is reconnected to a new blood supply and to a new nerve input, which restores 
muscular contraction. The survival rates in free flaps have steadily improved over time, however 
the functional outcomes in muscle transfers remain less predictable. In the case of facial 
reanimation the final results are a complex mixture of symmetry both at rest and in movement. 
This relies on striking a balance between muscular power, bulk and excursion in a muscle that 
gradually atrophies and then re-innervates over eighteen months to two years. A recent series of 
637 muscle transfers for facial reanimation graded 20% of results as sub-optimal (54). These are 
muscles that either have too little movement or, perhaps more depressingly, initially good results 
that have become tight and contracted over time. The underlying cause of these poor results is 
unclear. The best results for FFMT are in children under ten years old, and they are not reliably 
satisfactory in patients over fifty five (54,55). This is probably due to impaired neural 
regeneration in older subjects. 
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The two-stage facial reanimation with a free-functioning muscle transfer was first described in 
the late 1970s (46,47,49,56-58). At the first operation a nerve graft is harvested, normally the 
sural nerve. This is reversed to reduce the chance of regenerating axons getting lost at old 
branching points. What was the distal end is connected to a terminal arbor of the buccal branch 
of the facial nerve on the un-paralysed side of the face. The remaining length is then tunneled 
under the skin to the opposite, paralysed side as a cross-facial nerve graft (CFNG). Growth 
through this graft is tracked using a Tinel’s sign where sensation is provoked by tapping the 
growing end of the nerve. The presence of this Tinel’s sign is confirmation of the presence of 
some sensory fibres within the facial nerve. The second stage is performed when the CFNG has 
regenerated axons across the face to a sufficient length so that when it is connected to the new 
muscle the delay in reinnervation is a short as possible. Regenerating axons grow at 
approximately 1mm per day and the CFNG is usually 15 cm in length. Whilst the timing of the 
second stage depends on the individual, most axons will have traversed the graft after five or six 
months. A muscle is then harvested (usually the pectoralis minor, a segment of the latissimus 
dorsi or gracilis) and inserted into the paralysed cheek. Its blood supply is restored by connecting 
its vessels to the facial vessels and its nerve is connected to the freshened end of the CFNG. The 
muscle ends are sutured to the corners of the nose and mouth, and to the zygomatic fascia in 
front of the ear to recreate the vector of smile that is seen on the unparalysed side for that 
individual (Fig 2). 
  
	 21	
Figure 2. 
Two-stage facial reanimation procedure 
 
	
a)       b) 
The first stage operation involves the placement of a cross-facial nerve graft from the functioning 
facial nerve to the paralysed side. The second stage transfers a muscle into the cheek, restores its 
blood supply and connects it to the end of the graft. 
a) A cross facial nerve graft (CFNG) from the normal right facial nerve buccal branch to the 
paralysed left cheek. 
b) A free-functioning muscle graft in the left cheek anastomosed to the facial blood vessels 
and the CFNG. 
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1.4 Evaluating Free-Functional Muscle Transfers 
This procedure is arguably amongst the most intricate operations in modern surgery. The 
outcome depends upon a combination of technical expertise, aesthetic judgment, and the 
unpredictable element, the adequacy of the reinnervation of the muscle by the new nerve. Even 
with microsurgical techniques the reinnervation of muscles by peripheral nerves is far from 
perfect. The results of facial reanimation are subjective and hard to assess. There are a number of 
grading systems quoted in the literature that all rely on a combination of a score given by the 
operating surgeon and a score from an independent panel (49,54,59-64). The aim is to relate the 
outcome to the goals. In the case of the reconstruction of a smile these are symmetry, both at 
rest, and during movement, and the degree of excursion, by which we mean how much 
movement the muscle produces at the corner of the mouth. In addition there is the spontaneity of 
the smile, something that is very difficult to provoke in the relatively sterile environment of the 
clinic or hospital photographic department and often it can only be captured in unguarded 
moments. Ho has pointed out that the patient satisfaction is often absent from these grading 
systems (65). All the complexity of the smile is boiled down to excellent, good or poor. 
Excellent and good both encompass results where the muscle transfer has been successful and 
there is some movement recreating a smile, but variable degrees of symmetry. This is usually as 
a result of inadequate contraction of the muscle or an inferior vector of contraction due to its 
placement. Poor results represent 20-49% of cases and can occur for a number of reasons 
(54,59,66). All free tissue transfers, even when they are not free-functioning muscle transfers, 
have a failure rate associated with their blood supply of 5-10% (67). Even if the muscle survives 
in 7-11% of cases it will not re-innervate which results in little or no movement (54,68). There 
can also be synkinesis where the new muscle doesn’t contract synchronously. This is thought to 
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be due to imperfect reinnervation of the transferred muscle. Perhaps most disheartening is late-
onset tightness seen in 8-13% of muscles (54,68). This occurs when a muscle that was initially 
working well seems to tighten up and contract within the cheek over the course of a few years. 
Overall approximately one fifth to half of patients have an unsatisfactory result (54,59,66). The 
underlying process that results in these poor outcomes remains unclear. It is probably due to 
problems with the reinnervation of the muscle. 
It has been estimated that as many as 90% of all nerve repairs leave some degree of deficit 
despite achieving return of function, be that sensory or motor (69,70). Repairs that require a graft 
have a poorer outcome than a simple repair of the proximal and distal stump (71-73). It is not 
clear if this is simply due to there being two repairs instead of one. Investigations into possible 
nerve graft substitutes have tried everything from freeze-thawed muscle tissue, veins and even 
synthetic conduits, but none have consistently compared favourably with autograft of a host’s 
own nerve (71,74,75). 
It is a given that in free functional muscle transfers that once a muscle has been transplanted the 
new source of innervation (the donor nerve) will be different from its original nerve. Nerves can 
be composed of a number of different types of axons depending on their function. They can be 
purely sensory, motor or mixed, and within that there is variation in the properties of the 
individual axons according to their role (Table 1). The effect of connecting a muscle to a nerve 
that has a different makeup of axons from its original supply is poorly understood. MacQuillan 
has shown, by transplanting a hindlimb muscle in a rabbit model, that attaching a muscle to a 
peripheral nerve with more axons than its original does not improve the functional outcome (76). 
However, in the same scenario, comparing cranial nerve branches with differing numbers of 
axons, there is a difference in the tension generated. The larger of the two branches produced 
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more tension than the repaired original nerve, though still less than the uninjured muscle (77). It 
would seem that cranial nerves are capable of increasing the functional output of a muscle in a 
way that peripheral nerves are not. In trying to model facial reanimation it would seem prudent 
to use a cranial nerve. 
Moreover, it would seem logical to try and match the properties of the original and donor nerves 
to minimise the discrepancies in reinnervation. There is very little in the literature regarding the 
axonal composition of the branches of the facial nerve or of nerves supplying the muscles 
commonly used for functional muscle transfer in humans (78). Frey has investigated the medial 
pectoral nerve which supplies pectoralis minor. It has 1500 axons which are all myelinated with 
an average diameter of 8.5µm (79). The other two mainstays of facial reanimation, the latissimus 
dorsi and gracilis muscles, remain relatively undescribed in humans. Terzis has biopsied the 
nerve from the donor muscle in 35 patients undergoing a second stage free-functional muscle 
transfer for facial reanimation. She doesn’t clarify which muscle was being transferred in each 
case but states that the axonal load was 1222 ± 324 (80). 
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Table 1. 
Axon subtypes and properties 
 
	 Type	 Erlanger-
Gasser	
Class	
Diameter	
(µm)	
Myelin	 Conductance	
(m/s)	
Function	
Motor	 α	 Aα	 13-20	 Yes	 80-120	 Muscle	fibres	
Motor	 γ	 Aγ	 5-8	 Yes	 4-24	 Muscle	 spindles	
(efferent)	
Sensory	 Ia	 Aα	 13-20	 Yes	 80-120	 Muscle	 spindles	
(afferent)	
Sensory	 Ib	 Aα	 13-20	 Yes	 80-120	 Golgi	 tendon	
organ	
Sensory	 II	 Aβ	 6-12	 Yes	 33-75	 Muscle	 spindles	
(afferent),	
Cutaneous	
mechanoreceptors	
Sensory	 III	 Aδ	 1-5	 Thin	 3-30	 Cutaneous	 pain,		
touch,	 pressure,	
cold	
Sensory	 IV	 C	 0.2-1.5	 No	 0.5-2	 Cutaneous	 pain	
and	heat	
Autonomic	 Pre-ganglionic	 B	 1-5	 Yes	 3-15	 	
Autonomic	 Post-ganglionic	 C	 0.2-1.5	 No	 0.5-2	 	
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In a study of 30 patients undergoing two-stage reanimation Jacobs took biopsies from the stump 
of the buccal branch of the facial nerve at the first stage operation At the second stage several 
months later he also took biopsies of the cross facial nerve graft to compare the characteristics of 
the original nerve and the graft. He found that the total number of axons doubled from 5500 in 
the biopsy of the buccal branch to 11,500 at the distal end of the graft. Jacobs concluded that a 
buccal branch, via a cross facial nerve graft, provided an adequate number of axons to power a 
functional muscle transfer. However, the number of myelinated axons fell by over half and as a 
proportion of all fibres dropped from 31% to 4%.  The diameter of the regenerated axons was 
small with an average of 2.5µm and a maximum of 3µm (81). Given what we know about the 
anatomy of the facial nerve it is hard to explain the presence of so many unmyelinated fibres in 
the normal buccal branch. The increase in the number of axons suggests that there has been a 
substantial amount of branching within the graft, something supported by other work on nerves 
that are regenerating without target organs (82,83). Jacobs took the biopsy of the distal nerve 
graft prior to the insertion of the new muscle at the second stage. The lack of a target muscle 
during regeneration would have influenced the nature of the axons growing through the graft. In 
one case where a functioning muscle had to be revised after five years for unrelated reasons the 
proximal graft was re-evaluated. It now contained fascicles "packed with large regeneration 
clusters of well myelinated fibres with a maximum diameter of 13µm". Unfortunately the 
number of fibres is not mentioned. This suggests that the cross-facial nerve graft without a target 
muscle has a different composition from one that is connected to a muscle. Terzis performed a 
similar study in a number of patients undergoing a variety of facial reanimation procedures. 35 
underwent free-functioning muscle transfer (vide supra). Biopsies of the facial nerve showed that 
the zygomatic branch (998±705, n=59) has more axons than the buccal branch (683±506, n=25) 
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which correlates with MacQuillan’s work in rabbits (77,84). The sural nerve contained 1762 ± 
953 (n=37) axons at the first stage but at the time of the second stage this had fallen to 453±265 
(n=34). Interestingly she compared these axonal counts with the final clinical outcomes. A donor 
nerve with more than 900 axons correlated significantly with an improvement in functional and 
aesthetic outcomes. The only other significant finding was a correlation between the number of 
axons in the donor nerve and the number of axons at the distal end of the graft. Terzis does not 
give any raw data regarding the number of axons that were myelinated but she does mention that 
the number of myelinated axons in the distal nerve graft correlated with the counts at the donor 
nerve, but not with improved outcome (84). The differences in nerve composition and the 
changes that occur in axons after repair would seem to be likely contributing factors to the 
variability in results. 
There is a considerable amount of literature on the reinnervation of muscles after nerve injury, 
either nerve crush, nerve cut or nerve repair (85-103). However the methods available until 
recently have meant that investigation has been reliant on indirect measurements from techniques 
such as electrophysiology to estimate the size of axons and their motor units. Even retrograde 
labeling, which can highlight the number of nerve cell bodies in the central nervous system that 
have made projections to a target, cannot separate out those axons which made functional 
connections, from those that were misdirected there and make no contribution (104). Actual 
visualization has necessitated segmentally dividing up the nerve-muscle complex and imaging it 
sequentially. Serial sections in the electron microscope which can provide immense resolution 
have, to date, only been used to reconstruct relatively small volumes of neuropil (105). It is not a 
suitable tool to reconstruct the entire picture from the proximal nerve, through an area of injury, 
into the muscle and onto the neuromuscular junction. The recent advent of transgenic animals 
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that can express green fluorescent protein in their neurons now makes it possible to visualize 
neurons in continuity and trace their pathways both intra and extra-muscularly. It is possible to 
evaluate reinnervation in a completely new way and unpick the relationship between the 
returning axons and the muscle they are reinnervating. 
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1.5 Neurons 
Our current understanding of the structure and function of nervous tissue had its beginnings with 
the work of Golgi and Cajal just over a century ago. Before that the prevailing view was that the 
brain was a gland and the nerves conduits to transport the fluids, which it produced around the 
body. In 1873 Camillo Golgi developed a histological technique for staining nervous tissue with 
silver. The silver offers the dual advantage of being fully absorbed by a neuron along its entire 
length, but only being taken up in a small proportion of the total number of cells. This allowed 
Golgi to study cells in isolation without background noise from its neighbours. It was Ramón y 
Cajal who then applied this technique, and through his observations of neuron structure 
developed many of the fundamental tenets of modern neuroscience (106). He recognized that 
there was connectional specificity. Neurons had no cytoplasmic continuity but formed precise 
connections, and those connections were not random but organized. He also elucidated that 
within each neuron information always flows in a very organized pattern of dynamic 
depolarization. A signal arrives at a set of receiving sites (dendrites and sometimes the cell body) 
and then a trigger zone (axonal hillock) initiates an action potential which propagates in one 
direction down the axon to the pre-synaptic release sites in the axon terminal. This work at the 
end of the nineteenth century dramatically altered the paradigm for studying the nervous system, 
and initiated the neuronal doctrine: this states that the system is made up of individual cells 
capable of producing signals and communicating between one another via connections. It was 
supported by concurrent research in related disciplines. Harrison used tissue cultures to study 
embryological development, and showed that the dendritic and axonal processes of the neuron 
are continuous with the cell body and project from it. He also demonstrated the presence of a 
growth cone at the tip of the advancing axon as it extends towards its target organ (107). 
	 30	
Physiological work by pioneers such as Galvani and von Helmholtz unraveled some of the 
mysteries of the electrical activity of nerve cells and how signals were conducted along their 
processes. Pharmacologists such as Bernard, Ehrlich and Langley, showed how drugs could 
interact with receptors on the surface of neurons, and started the process of understanding the 
way the electrical impulses are converted to a chemical signal at the synapse (108). 
 
Neurons can be classified according to their connections and their structure. Afferent neurons 
carry signals into the nervous system. Efferent neurons carry signals away towards effector 
organs such as muscles and glands. Inter-neurons carry signals between other neurons and make 
up most of the cells within the brain. A typical motor neuron is a multipolar cell with its cell 
body located in the anterior horn of the spinal cord. It has 7 – 18 primary dendrites, which gather 
information, and a single axon which propagates information over a variable distance to the 
presynaptic terminal (108). If a threshold membrane potential from the dendritic inputs is 
reached an axon potential is initiated in an all-or-nothing signal (109). Once the axon reaches the 
muscle it ramifies into an arbor and each branch ends at a neuromuscular junction (NMJ). Here 
the terminal swelling of the axon contains vesicles that deliver the neurotransmitter acetylcholine 
into the synaptic cleft. A single axon from each nerve cell will connect to multiple muscle fibres, 
but each mature muscle fibre will only receive input from a single axon. The fibres collectively 
innervated by each nerve cell are defined as a motor unit, and within a single muscle there will 
be a distribution of units of varying sizes. The proportion of small to large units and their orderly 
recruitment dictates the overall function of the muscle (110). Henneman postulated that within 
each muscle the motor units are recruited according to the size principle: smaller units are 
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excited first and most often. Larger units are added to them as the size of the stimulation is 
increased and more power is required from the muscle (111,112). 
 
One of the key defining characteristics of nerve cells is their excitability. This feature results 
from changes in electrical potential difference across the cell membrane due to the rapid shift of 
charged ions between the intra and extracellular spaces. This shift depends on the ion channels 
that span the phospholipid bilayer of the cell membrane, which can initiate a wave of coordinated 
depolarisation as an action potential. The speed with which this signal can travel is dependent on 
electrical resistance of the membrane and axonal cytoplasm. This resistance is inversely 
proportional to the diameter of the axon. However, it is advantageous to keep axon diameters 
small to maximize the number of conduits available to transmit large volumes of information to 
and from the periphery. Insulating the axons by wrapping them in myelin reduces the resistance 
by more than an equivalent increase in axonal diameter (108). 
 
Glial cells, are intimately associated with nerve cells and their signal transduction properties. 
Schwann cells are the glial cell of the peripheral nervous system. These cells are not actively 
involved in signal processing but they play important roles in supporting and nourishing the 
axons. They buffer potassium ion concentrations, phagocytose debris (see nerve injury below) 
and assist in axonal migration and growth guidance. Schwann cells produce myelin which wraps 
around each axon in concentric rolls to sheath and insulate them (108). Myelin is very similar in 
structure to plasma membranes consisting of 70% lipid and 30% protein, with a high 
concentration of cholesterol and phospholipid molecules. In development, before myelination, 
the nerve cells lie in a trough formed by rows of adjacent Schwann cells. These then surround the 
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axon and form mesaxons, a double-membraned process that then spirals around the axon as it 
elongates. As it does this, the cytoplasm of the glial cell is squeezed out and the concentric rings 
condense into a lamellar structure called the myelin sheath. The axon makes contact with the 
muscle at neuromuscular junctions which tend to be gathered in a region of the muscle defined as 
the end-plate zone. The myelin sheath terminates just short of the point where the axon forms 
thin tendrils that branch out over the junction. A non-myelinating Schwann cell variant covers 
the junction. 
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1.6 The neuromuscular junction 
Once an action potential has travelled the length of an axon it arrives at the synaptic terminal. 
Much of nerve anatomy is concerned with the rapid and precise conduction of information 
between two cells over a considerable distance. Within the cell processes, both dendritic and 
axonal, this is in the form of an electric potential. The point of contact between cells is called a 
synapse. Synapses can vary greatly depending on the anatomy of the pre and post synaptic cells 
and the function they perform, but it is vital that the speed and precision of the action potential 
be maintained. In most cases the signal is transferred by the conversion of the electrical signal to 
a chemical one at the synaptic junction, which then influences the postsynaptic cell. This is uni-
directional and can be excitatory or inhibitory, and expressed through a myriad of 
neurotransmitters (e.g. acetylcholine, noradrenaline, serotonin, dopamine, g-aminobutyric acid). 
The type of transmitter is specific to the pre-synaptic cell and, once mature, that cell only 
secretes that transmitter at all its synapses, however the same neurotransmitter may have 
excitatory effects on some postsynaptic cells and inhibitory effects on others. The 
neurotransmitter at the neuromuscular junction (NMJ) is acetylcholine (ACh) which acts in an 
excitatory capacity via a nicotinic receptor on the surface of the muscle fibre. ACh is synthesized 
from the non-specific metabolic substrate acetyl coenzyme A (acetyl CoA) by the substitution of 
choline for CoA by the enzyme acetyltransferase (108). 
 
When the action potential arrives at the terminal it opens voltage-gated calcium channels which 
results in a secretory potential at the bouton (108). Thousands of vesicles containing ACh fuse 
with the presynaptic membrane releasing ACh by exocytosis.  A concentration of ACh receptors 
reside in the post-synaptic membrane and are associated with voltage-gated sodium channels. 
	 34	
The receptor is a transmitter-gated ion channel with a central pore that is large and non-specific. 
It allows passage of potassium, sodium and even calcium ions. During the millisecond that ACh 
is, on average, bound to its receptor there is a net influx of sodium ions and efflux of potassium 
ions resulting in a depolarization of the membrane. ACh channels can only be opened by binding 
with ACh and are therefore limited to the concentration of ACh molecules in the cleft. This 
keeps the size of the depolarization proportional to the concentration of ACh released. This 
concentration peaks at the moment the action potential initiates the exocytosis of the vesicles in 
the presynaptic membrane, then fades due to diffusion of ACh out of the cleft and the action of 
acteylcholinesterase. The depolarization caused by the ACh receptor channels opens the voltage-
gated Na+ channels which then instigate a positive feedback loop. This is sufficient to provoke 
an action potential in the muscle fibre. The area on a muscle that is in contact with a nerve 
contains all the neuromuscular junctions and is known as the end-plate band. Once the action 
potential arrives at an NMJ it generates an end-plate potential which propagates along the surface 
of the muscle. 
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1.7 Nerve Injury 
Peripheral (PNS) and central (CNS) nerves have very different responses to injury. Centrally the 
ability to repair damage is very limited. Neurons cannot regenerate axons. In contrast neurons in 
the periphery are able to re-grow axons over large distances and re-establish connections to 
target organs. The exact mechanisms behind these differences are not fully understood. There are 
theories suggesting that it might be due in part to differences in the extracellular matrix that 
surrounds the injured nerve cells. Cajal noted that by bringing the proximal end of an axotomised 
nerve in the PNS into contact with CNS by transplanting a segment of optic nerve, it 
immediately arrested any regeneration (113). In contrast when a segment of rat sciatic nerve 
(PNS) was grafted onto an axotomised optic nerve (CNS), nerve fibres were encouraged to 
regenerate (114). 
 
When an axon is severed axoplasm seeps from the cut ends of both the proximal and distal 
segments. This stops once the axonal membrane seals across the open ends. The ends then swell 
and retract away from one another as they fill with the substances that normally travel along the 
axon. The discontinuity of the axon means that the proteins synthesized in the cell body can no 
longer reach the terminal bouton. Synaptic transmission rapidly ceases as it cannot regenerate 
vesicles. The nerve segment that is not in continuity with the cell body begins to degenerate. This 
process was first described by Augustus Waller in 1850 (115) and has become known as 
Wallerian degeneration (WD). The cytoskeleton of the axon forms into clumps and disintegrates 
into a ‘string of beads’ mediated by calcium influx which activates axonal proteases (116). 
Depending on the size of the nerve there is disintegration of the axon within one to two days 
(117). During this time the myelin sheath also pulls away from the axon and breaks apart. The 
	 36	
proximal axon stump retracts back to the next node of Ranvier. The cell body swells and 
undergoes a series of changes known as chromatolysis (100). The nucleus increases in size and 
moves away from the centre of the cell towards the axonal hillock and the rough endoplasmic 
reticulum breaks up. The cell switches from a state of signal transmission to one of growth, and 
with that there is a change in gene expression with up-regulation of those genes responsible for 
growth cone elongation and stability (118). mRNA and protein synthesis is accelerated to 
support axon growth (119). These genes include those for cytoskeletal proteins (tubulin and 
actin) and growth associated proteins, especially growth associated protein-43 (GAP-43) and 
cytoskeleton-associated protein-23 (CAP-23) (120,121). Regenerating axons are thinner than 
normal due to the down-regulation of genes for neurofilament cytoskeleton production and 
therefore reduced neurofilament:tubulin ratio within the growing axon (122,123). 
 
Within two days the Schwann cells dedifferentiate and down regulate the genes that produce 
myelin, which would normally support axonal transmission (124). There is a highly coordinated 
up-regulation of regeneration associated genes (RAGs) which code for neurotrophic factors 
(nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and glial cell derived 
neurotrophic factor (GDNF), cytokines and cell adhesion molecules (125). Schwann cell 
proliferation occurs in a non-myelinating form that promotes axonal growth (126,127). These 
cells scavenge myelin debris from the fragmenting sheath and form it into ovoids, the classical 
'ground glass' appearance associated with Wallerian degeneration (128-130). Release of nerve 
growth factor (NGF) causes Schwann cells to migrate across the site of injury and form bands of 
Büngner which are important in supporting and guiding the regenerating axons (131-133).  
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Macrophages infiltrate the site by the third day post injury, and remain in the nerve stump for at 
least a month. They are the principle agent for removing the myelin debris such as myelin 
associated glycoprotein (MAG) which is inhibitory to axonal growth (134-139).  
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1.8 Nerve growth and regeneration. 
The proximal stump develops a growth cone similar to that seen in development. Axons grow by 
adding components at their distal extremity at an area known as the growth cone (140-142). This 
cone was recognized by Cajal, but he imagined it to be akin to a simple snowplow that opened 
the route within the packed stroma for the axon to pass through (143,144). The presence of 
filopodia extending out from the growth cone were first noticed by Harrison working with 
embryonic neural tubes in cultures, and then by Speidal in vivo in tadpoles (145,146). It appears 
that growth cones have two potential morphologies (147). When the axon is following a path that 
has already been laid down by previous axons the growth cone is exactly that, a cone, with very 
few filopodia. However, when it reaches an area where a ‘decision’ has to be made: to 
defasiculate, follow an alternative path, or contact with a target, the cone flattens out and forms 
multiple filopodia (148-150). The increase in axonal length occurs at the growth cone tip (151). 
The production of new membrane mainly occurs through the calcium-dependent fusion of 
vesicles at the tip of the cone (152). Likewise the polymerizastion of axonal architecture, of 
tubulin into microtubules and actin into microfilaments, also occurs at distal tip of the axon  
(153-157). Microfilaments seem to be more important for growth of the filopodia, whilst 
microtubules are concerned with advancement of the whole growth cone (158). Filopodia are 
capable of generating retrograde tension that drags the axon forwards (159). This allows them to 
affect the direction of the growth cone as they interact with their surroundings. Growth cones are 
guided towards their targets by a number of processes. They are able to respond to physical and 
chemical signals in their local environment1. In this way they interact with the substrate they are 
																																								 																					1	Guidance of axonal growth cannot be explained entirely by physical means. In experiments where the optic nerves 
were transplanted to different areas of the brain they still managed to find their correct targets (160). The 
adhesiveness of the surface the axon is grown on also makes a difference to the activity of the growth cone (161-
165). McKenna et al showed that there is a threshold concentration of adhesion molecules required to facilitate 
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growing on as well as adjacent cells, cell adhesion molecules and diffusible agents that can 
promote or inhibit growth. Experiments have shown that growth cones can be impeded by 
physical breaks in the tracts they would normally follow, but that they can also be facilitated by 
an artificial pathway (184). This underpins how we can use nerve grafts to overcome gaps in 
injured nerves. 
 
As the growth cone extends from the proximal nerve stump in regenerating axons it travels on 
the surface of the Schwann cell or along the inner surface of the basal lamina of the Büngner’s 
band (185). These have the dual function of providing a scaffold for regenerating axons to grow 
along and the adhesion molecules to encourage that growth (186-189). The Schwann cell 
columns and the denervated target both produce neurotrophic factors that support the growth of 
axons (102,190,191). Multiple growth cones form, with each of the damaged axons producing on 
average 5 branches and some of those can co-exist within a single Schwann cell column or basal 
lamina tube (82,98,101,192,193). If the nerve reaches a target the number of fibres shrinks and 
the average size of each axon increases. It is thought that the reduction in branches takes place 
through pruning of those that have not made adequate or appropriate connections (94,95). This 																																								 																																								 																																								 																																								 																																			 	
growth but they are not necessarily instructive (166). There are numerous molecules in the extracellular matrix 
(ECM) that have been shown to promote axon growth (167). Whilst all can support growth some seem to be 
preferred by particular subsets of cells: CNS axons prefer laminin whilst peripheral axons prefer fibronectin. This 
specificity may lie in the makeup of the expression of integrin molecules at the tip of the growth cone (168). In 
addition the combination may alter as an axon matures and encounters different environments (169). Most axons 
grow along the surfaces of other cells and axons. These express cell adhesion molecules (CAMs) on their surface 
which support axonal growth and have a number of specialized functions. NCAM is probably the most studied of 
the CAM family. It seems to be expressed on all neurons and glia but can be highly modified in its extracellular 
portion and therefore exists in multiple forms (170). It is thought that this variation may assist in the direction of 
nerves as they advance through complex regions such as the brachial plexus (171). The family of CAMs seems to 
keep growing and interrupting their action produces a huge variety of changes in axonal growth. This has led to the 
‘labeled pathway’ hypothesis of axon guidance whereby a pioneer axon grows towards the target and lays down 
CAM signals that all subsequent axons follow (172-175). The understanding of how the original pioneer axons 
reaches its targets is still not clear though it is thought it might be through local cues or chemotaxis towards a 
diffusible signal from the target, as demonstrated by the ability of growing axons in culture to detect and grow 
towards a higher concentration of neurotrophic factor (176-179). This is a complex topic and one that is not 
resolved. It seems likely that growth cone guidance is a combination of attractive and repulsive forces acting in 
concert (180-183).  
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may occur through a process similar to that undergone in development, when competition 
between axons at polyinnervated neuromuscular junctions eventually gives way to single 
innervation (194-201). In regeneration it is unclear whether each axon is pruned back to a single 
fibre. Multiple collateral branches are capable of function as seen in synkinesis. Mackinnon has 
shown that the initially increased number of branches is reduced to normal levels after twenty 
four months in a rat model (202). However this doesn't allow for the natural reduction of axon 
numbers with ageing in a similar timeframe which can be as much as 30% (5). 
 
The size of regenerating axons change as they mature. Initially there is a large population of 
small, unmyelinated axons and as they mature they become fewer, larger and myelinated 
(82,203,204). The most important factor for the maturation of the regenerating axons is a 
connection with the target, regardless of the degree of target regeneration (82,205-207). 
However, target size has been shown, at least in sympathetic fibres, to be influential on the size 
of axons (185,208). The size of axons is also the deciding factor in their myelination, with all 
axons greater than 2µm becoming encased in a sheath (209). This may explain the 
disproportionate increases in unmyelinated axons over myelinated than have been reported 
(81,98,210). Branches that have not reached a target may stay small and therefore remain 
unmyelinated. Those that have made a connection with a target may be able to mature, enlarge 
and myelinate. Whilst the axon characteristics seem to be restored after nerve crush this is not 
the case after axotomy and repair where axons are noted to be smaller and slower with thinner 
myelin sheaths (86,204,211). Despite some recovery over time, the normal distributions are not 
regained (87,203). 
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Although axon damage and target denervation stimulate regrowth, it has long been known that 
the functional recovery is worse after periods of denervation (212-215). The assumption has been 
that this recovery problem is secondary to the severe muscle atrophy following chronic 
denervation (216). However, more recently this idea has begun to be revised, to incorporate the 
changes that occur in both chronically denervated axons and intramuscular Schwann cell sheaths. 
Regeneration of muscle fibres from satellite cells has shown that it is possible to maintain a 
normal number for as long as ten months post denervation (217,218). Bagust has shown that the 
number of axons crossing a fresh nerve repair is approximately 50% (219). If the repair is 
delayed this number falls to 35% by three months, and then remains stable for at least a year. The 
axons that do make connections (in this case to a freshly denervated muscle) are able to increase 
their motor unit size threefold, so that the functional recovery is complete  (220). This 
corresponds to the four to six fold increase in sprouting ability seen in uninjured axons 
expanding to occupy partially denervated muscles (221,222). However there is some evidence to 
suggest that whilst motor units two to four times larger than normal are stable, those four to six 
times are less so (222-225). Muscles that have been denervated for more than six months and 
reinnervated by freshly cut nerves do not recover as well. The returning axons still increase their 
motor unit size threefold but the number of motor units fell by 85%. This corresponds to fewer 
than 50% of the original muscle fibres being reinnervated (226). Interestingly this result was 
replicated with no delay by suturing the nerve directly to the muscle instead of to the distal nerve 
stump. Fu, in a rat model, suggests that this is evidence that poor reinnervation is due to the 
deterioration within the intramuscular nerve sheaths, as a result of either reduced numbers of 
Schwann cells secondary to poor trophic support, fragmentation of the basal lamina, or 
collagenisation of the endoneurial tubes. Rich has shown in mice that following nerve crush re-
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innervating axons accurately reoccupy old junction sites, and that new junctions are almost never 
established (227). Kang has shown in mice that the non-myelinating terminal Schwann cell that 
covers the neuromuscular junction, is involved in guiding axons back to vacant junctions (228). 
If the intramuscular sheath system deteriorated this would reduced the number of axons that 
manage to make connections with the original junctions. 
 
The patterns of nerve regeneration in muscle are dependent on the nature of the injury to the 
nerve. Nguyen, in mice, has shown that after nerve crush there is an extraordinary degree of 
accuracy of reinnervation with axons not only reoccupying their previous junctions but even 
repeating their original branching patterns. After axotomy this situation is reversed with almost 
total loss of the original connectome (103,229). Brushart, in a mouse model, noted that after even 
individual fasicular division and repair, retrograde labeling of the dorsal horn nuclei showed 
more diffuse staining than the tight segregation seen in controls (92). In the case of full axotomy 
this effect was compounded (230-232). If there are multiple possible targets for a regenerating 
axon this confusion is reinforced. Cutaneous sensory axons that do not reach the skin cannot 
provide useful information, and motor axons that do not reach muscles cannot induce 
contractions. Regenerating branches that arrive at different muscles will produce synkinesis. 
There is an extensive literature on factors that might influence axons to preferentially reinnervate 
motor branches over sensory ones (93,94,233-238). There remains some uncertainty as to 
whether this occurs at all, or is a feature of subsequent axon pruning as mentioned above, that 
helps to restore the connectivity patterns (94,97,194,200,201,239). This may be an evolutionary 
advantage of collateral branching as the wiring can only be revised when there are connections 
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made to 'good' and 'bad' targets. A motor neuron that only makes a cutaneous contact receives no 
trophic support and is unable to improve its situation (94).  
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1.9 Changes at the neuromuscular junction after denervation. 
Neuromuscular junctions in the neonatal period evolve from a plaque-like structure into the 
familiar pretzel shape during the process of synapse elimination. This is intricately associated 
with the conversion from poly to single innervation. Asynchronous stimulation from multiple 
axons elicits a loss in postsynaptic receptor density, which precedes the withdrawal of the 
overlying axon (197,240). As this progresses the plaque perforates and forms, resulting in the 
mature receptor morphology (201,241). These are relatively stable, enlarging uniformly with age 
through intercalary growth (242). After denervation there is total loss of the presynaptic signal. 
This total inactivity doesn’t result in immediate receptor disassembly, and junctions are lost 
gradually with the normal turnover of receptor sites in a process that can take several weeks 
(201). In reinnervated junctions Kang has shown that receptor areas that are no longer covered 
by the processes of terminal Schwann cells disappear (243). The area of receptor loss was 
increased with a delay in reinnervation after a double nerve crush. He has suggested that this 
may be akin to the mechanism of asynchronous receptor loss described by Rich. Areas of 
permanent receptor loss were seen where there was competition between axons at reinnervated 
junctions (197). Once the junction has become singly innervated, the areas of the receptor that 
were eliminated remained unoccupied, and new acetylcholine receptors were not inserted. These 
changes after reinnervation may resemble the characteristic changes that occur at the 
neuromuscular junction associated with senescence. There is often partial dissociation of the 
synaptic terminal from the receptor site leaving it partially innervated. In other cases there is a 
return to the polyinnervation of the neonatal period. The axon can become irregular, either very 
thin, or bulbous and varicose. The receptor area can become fragmented and break up into 
islands (5). These changes could represent a decreased efficiency of the neuromuscular junction. 
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1.10 Green fluorescent protein 
In 2008 Chalfie, Tsien and Shimomura were awarded the Nobel prize in chemistry for the 
discovery and development of green fluorescent protein (GFP). It was Shimomura’s painstaking 
work on the Aequorea victoria jellyfish that unraveled how it produced its bioluminescence 
through two proteins rather than the luciferin/luciferase pathway used by most other 
bioluminescent organisms. The first protein was a calcium binding protein, aequorin, that 
emitted a bluish light. The second absorbed that blue light and emitted a greenish one resulting in 
the moniker: green fluorescent protein, GFP (244). The gene for GFP was then sequenced by 
Prasher and subsequently inserted into the touch receptor neurons of Caenorhabditis elegans by 
Chalfie (245,246). Hazelrigg, Chalfie’s wife, manufactured a fusion protein which allowed GFP 
to be expressed and functionally replace an original protein, paving the way for GFP to act as a 
label for particular cells expressing that protein (247). Tsien expanded the spectrum of GFP to 
produce a range of fluorescent proteins emitting wavelengths from 440nm to 648nm (248) (for 
review see (249)). GFP is a protein that requires no co-factors to render a cell fluorescent, and 
results in a label that is non-toxic and stable both in live tissue and after fixation. It has no impact 
on normal developmental or ageing changes and is still present in axons that have been injured 
and subsequently regenerate. By fusing it to particular proteins it can be used to label specific 
subgroups of cells (250). Combining GFP with the thy-1 gene promoter created transgenic mice 
where the GFP is expressed in several neuronal types but almost not at all outside the nervous 
system. The transgene is inserted randomly into the chromosome which generates large variation 
between lines in the cell subtype and proportion of axons where GFP is expressed. However 
there is minimal inherited change once the expression is established giving stable transgenic 
lines. This, and the use of spectral variants of GFP, has provided a number of tools to study 
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nerves (250). Lines can be generated that express GFP in all axons (YFP-16), or a few as 5-10% 
(YFP-H), akin to the sparse silver staining of Cajal and Golgi. Combined with more traditional 
labeling of neuromuscular junctions with bungarotoxin conjugated to alexa-fluorphores it is 
possible to build up a picture of the entire nerve-muscle complex that can be studied both in vivo 
and in vitro. Single motor units can be mapped as opposed to inferred (251,252). By mixing lines 
it is possible to generate lines in which axons of more than one colour are expressed in a single 
nerve. As such the behaviour of a single axon can be picked out against all of its neighbours, or 
two motor units can be labeled and their interactions observed (253,254). Nguyen has used YFP-
H mice to investigate patterns of reinnervation after nerve crush (103). Here I have used the 
same approach, but adapted it to a model mimicking facial palsy to examine the changes 
occurring in a nerve-muscle complex after nerve repair and nerve graft. 
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1.11 Hypotheses. 
The aim of this study is to get an overview of the changes taking place across the entire 
neuromuscular system in the context of reinnervation. I wanted to follow a regenerating axon 
from the proximal stump, through a nerve repair or graft, right into the muscle to the junction. 
To do this I have used two lines of transgenic mice that express yellow fluorescent protein in 
their axons: YFP-16 expresses in all axons, the YFP-H in approximately 5-10%. The YFP-16 
allowed me to study the overall reinnervation patterns of the whole muscle. The YFP-H mice are 
more akin to the silver staining used by Cajal, enabling me to see the regenerating pathways of 
just a few axons, without the background noise of the entire nerve. 
Cross sections of the axons at proximal and distal sites in the terminal branch to the muscle 
provided data on the number of axons, the amount of branching, and their caliber. Antibody 
staining reiterated the proportion of these axons that were myelinated. 
Labeling neuromuscular junctions with alexa-594-bungarotoxin illustrated the number of 
junctions that were reoccupied by the regenerating axons as well as any changes in the 
morphology of the junctions. 
 
The first null hypothesis is that there is no difference in the pattern of neuromuscular innervation 
between a control muscle and a muscle that has been reinnervated after a complete division of 
the nerve and restoration of continuity. 
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The second null hypothesis is that there is no difference in the pattern of neuromuscular 
innervation whether that restoration of continuity occurred through a nerve repair or a nerve 
graft. 
 
Both of these hypotheses are broken down to focus on specific markers of reinnervation: 
a) the reoccupied neuromuscular junctions 
b) the regenerating axons 
c) the reinnervated motor units 
  
	 49	
2.  Methodology 
 
2.1 Transgenic Mice 
All experiments were performed in transgenic mice originally produced in the Lichtman 
laboratory at Harvard University. The genetic lines are maintained internally by individual 
researchers and pure colonies by a technician. The genetic lines are available through Jackson 
Laboratories (Jackson Laboratories, Bar Harbor, Maine, USA). All surgeries took place with 
both National Institues of Health (NIH) and Institutional Animal Care and Use Committee 
(IACUC, USA) approval. These ethical standards are equivalent to standards set out by the 
Animal Welfare and Ethical Review Body (AWERB) under the Animals (Scientific Procedures) 
Act, UK. 
 
 YFP-16 is a line that expresses yellow fluorescent protein in all axons in both sensory 
and motor nerves (255). These animals were used to study the reoccupation of neuromuscular 
junctions and regenerating axonal load. 
 
 YFP-H is a line that expresses yellow fluorescent protein in approximately 5-10% of 
axons in each nerve (255). These animals were used to look at branching patterns within the 
regenerating nerve. 
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2.2  Interscutularis 
The interscutularis is a superficial muscle that crosses the parietal skull and connects the 
cartilaginous base of the ears. It is encased in loose connective tissue and embryologically 
derived from the panniculus carnosus so it has no bony connection, in keeping with the muscles 
of facial expression in humans. In the midline there is no definitive aponeurosis and the muscle 
fibres of each side interweave directly (Fig 3). 
 
The interscutularis is innervated by a branch of the posterior auricular nerve (PAN), itself a 
branch of the facial nerve. The facial nerve exits the stylomastoid foramen of the skull caudal to 
the base of the ear. The nerve passes cephaladad and immediately divides into two main trunks, 
one passing ventrally under the ear to become the five branches to the face, the other passing 
dorsally as the posterior auricular branch (Fig 4). This travels deep to the parotid and a fat pad 
between the mastoid process and the external ear (3). 
 
The PAN divides into 4 or 5 main branches before it arrives at the posterior surface of the 
conchal bowl. These run parallel to each other in close proximity to the cartilage of the posterior 
auricle and supply the superficial muscles of the dorsal neck and head (levator auris longus, 
interscutularis, auriculolabialis, cervical platysma). 
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Figure 3. 
The interscutularis muscle 
 
Anatomical drawing of the anatomy of the interscutularis muscle in a rat. Anatomically the rat 
and the mouse are identical in this regard. There are no anatomical atlases of the mouse that 
show this degree of detail.  (3) 
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Figure 4. 
The facial nerve in the rat 
 
 
 
Anatomical drawing illustrating the course and branches of the facial nerve in the rat  (3). There 
is no equivalent anatomical atlas showing this degree of detail in a mouse, but the anatomy is 
very similar between the species in this regard.  
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2.3 Pilot studies (various XFP lines) 
10 animals were used to explore the dynamics of nerve repair and nerve graft. Initially (n=5) this 
followed a protocol previously used in the Lichtman laboratory focused on the sternomastoid and 
cleidomastoid muscles (103). 
 
Anatomical studies were performed to develop the surgical approach to the interscutularis and 
posterior auricular nerves. It was essential that the operation to carry out the nerve division, 
repair or graft should not violate the tissues around the muscle and induce scarring. It was also 
necessary for the nerve to be accessed at a location where its calibre was large enough to 
facilitate neurorraphy. 
 
In the pilot methodology for this study we planned to use the contralateral muscle as a control in 
each specimen. The interscutularis muscle inserts laterally into the cartilage of the ear on its 
superior and posterior aspect. In the midline its fibres interweave with the muscle from the other 
side. There is no bony attachment and the muscles are separated from the skull on their deep 
surface, and the platysma superficially by layers of loose connective tissue. This allows the 
muscle complex to slide freely over the skull as the ear moves cranially or caudally. It also 
means that the insertion of the muscle into the ear on one side acts as the anchor point for the 
action of the muscle on the opposing side. The effect of a contraction on one side can therefore 
be transferred across the midline. There are very few muscles (the orbicularis orii and the anal 
sphincter, for example) that have this kind of action across the midline of the anatomy. In pilot 
studies it was apparent that there was significant variation in the number of neuromuscular 
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junctions between specimens. There was no evidence for right or left dominance (p=0.4, see 
figure 17) but the variability within each individual (p=0.01, see figure 18) was sufficient to 
make comparisons between them invalid.  This made the use of the contralateral interscutularis 
from each specimen as a control impractical. A separate cohort of specimens where no 
interventions had been performed, matched for age and weight, were used as a control group. 
 
All animals in the anatomical pilot studies came from a pool of adult mice of various fluorophore 
lines (Green FP, Cyan FP, Yellow FP) that were otherwise allocated for euthanasia. 
 
In honing the methodology for this study we explored several other avenues that were eventually 
excluded. 
The use of native fluoroescent protein expression to identify structures in vivo is a new and 
powerful technique to understand biological events. In this study we have used YFP to focus on 
regenerating axons in the facial nerve. However, XFP technology has expanded in its scope 
significantly since Chalfie first managed to splice it into the genome of the C.elegans. Lichtman 
has been working on exciting variants such as the Brainbow mouse where multiple fluorophore 
colours are inserted into the genome and each gene is turned on randomly. This generates a 
palate of colours and allows each axon in a nerve to have a different hue [Livet 2007]. We 
attempted to use the technique of multiple fluorescent labeling within our methodology to 
answer two questions. Firstly we attempted to use a double transgenic CHAT Cre:Thy 1 mouse 
to identify exclusively motor axons. In these animals the YFP gene would only be expressed in 
axons that produced actylcholine and therefore would preferentially label motor axons over 
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sensory ones. Secondly we attempted to produce a line of S100 CFP:Thy 1 YFPdouble 
transgenics. In these animals we hoped to label the schwann cells with one colour of fluorescent 
protein (cyan) and the axons with another colour (yellow). This would negate the need for 
separate immunohistochemical labeling of the myelin. Unfortunately, both these lines proved to 
suffer with very poor fertility. We only managed to breed very small numbers, insufficient for 
any experimental groups. 
 
Measures of functional outcome, such as toe spreading, have been described when investigating 
functional outcomes in the hind limbs. There is no such outcome measure with respect to the ear. 
We tried to develop a technique to assess ear movements using video of a number of white dots 
of paint on the rim of the ear. The theory was that we could measure the range and scope of 
movement in the normal ear and the denervated ear and compare the quality of the muscle 
reinnervation. This proved technically impossible. We could not reliably get standardised video 
footage of the mice. We couldn’t keep the animal in a standarised position with some degree of 
anaesthesia which then affected ear movement. When footage was achieved it proved too 
complex to define a “normal” range of ear movement, let alone quantify the change seen in 
reinnervated muscles. 
 
One of the main aims of this study was to investigate changes in motor unit size. A compromise 
of the study design is that by examining the terminal nerve to the muscle we were unable to say 
with certainty that there have not been axonal branches prior to the proximal sampling point. An 
alternative method of assessing the number of individual axons reinnervating the muscle would 
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be to perform retrograde labelling. This would label the cell bodies of the axons that had made 
connections with the muscle, independently of how many branches they had made as they 
regenerated. We set up a pilot study to look at this. I supervised an undergraduate student (K 
Lee) who performed this work as her final year neurobiology extended project. Unfortunately the 
location of the facial nerve nucleus within the brain stem, and thus within the skull, complicated 
this experiment. Results were inconsistent in control animals, and even more difficult to interpret 
in experimental animals and we ultimately abandoned the technique. 
  
	 57	
2.4 YFP-16 
YFP-16 animals were divided into four groups: 
One control group:   pure controls with no intervention (N), n=9 
 
Three experimental groups:  unilateral nerve repair (R), n=27 
unilateral nerve graft (G), n=27 
unilateral nerve cut (C), n=18 
 
R, G and C groups were equally subdivided into 3 time intervals (Table 2). 
 
Table 2. 
YFP-16 specimen distribution. 
Group/Time Controls (N) Cut (C) Repair (R) Graft (G) 
4 weeks 6 6 9 9 
6 weeks - 6 9 9 
12 weeks 3 6 9 9 
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2.5 YFP-H 
In the YFP-16 line we were looking for changes in the axon and NMJ populations during 
regeneration after nerve injury. The YFP-H line has sparse expression of the fluorescent protein 
so only 5-10% of axons are labeled. This is akin to the silver staining used by Cajal and Golgi 
which enabled single axons to be identified from the background noise of the entire nerve (106). 
The YFP-H was used to examine branching patterns after the nerve has reconnected to the 
muscle. Once axons have undergone remodeling unsuccessful axons are pruned and only the 
successful axons remain. The routes and branches that occurred during the process of 
reinnervation are preserved and represent a record of the axon regeneration process. 
YFP-H animals were allocated to the same experimental groups as the YFP-16 animals. 
However all Cut, Repair and Graft specimens were harvested at twelve weeks post-intervention 
(Table 3). This allowed for the process of reinnervation and remodeling to occur, giving a route 
map of the progress the successful axons took. In the Cut group only the neuromas on the cut 
side were harvested for analysis. 
Table 3. 
YFP-H specimen distribution between the control and experimental groups 
Group/Time Controls (N) Cut (C) Repair (R) Graft (G) 
4 weeks 1 0 0 0 
6 weeks 0 0 0 0 
12 weeks 3 3 5 2 
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2.6 Surgical protocols 
All surgery took place in adult mice of either sex between seven and eight weeks of age under 
NIH guidelines and an animal protocol approved by Harvard University Animal Studies 
Committee and the Standing Committee on the Use of Animals in Research and Teaching 
(IACUC, USA). Animals were anaesthetised using a standard mixture of Ketamine:Xyalazine 
(KX 17.38mg/ Lloyd Inc, Shenandoah, Iowa, USA) at 0.1ml/20g body weight. Deep sedation 
was verified using a standard foot pinch test. All surgeries took place in a warm, clean room 
using a Leica fluorescent operating microscope (Leica MZ 16FA, Leica Microsystems GmbH, 
Wetzlar, Germany). In transgenic animals this can greatly assist in accurate identification and 
dissection of relevant structures. With fluorescent illumination the nerves of YFP mice are easily 
visible as green/yellow against the background tissue (Fig 5). Animals were placed on gauze on a 
metal operating plate and retraction was performed with custom made retractors fitted to 
magnetic stands. 
 
Anaesthetised animals were placed in a right lateral position and the right lateral neck was 
depilated (Nair, Church and Dwight Inc, Princeton, NJ, USA) and the skin prepped with 70% 
alcohol solution. An incision was made caudal and parallel to the conchal bowl exposing the fat 
pad and the parotid gland. 
 
The tissue was blunt dissected away from the auricle taking care not to disrupt the posterior 
facial vessels, which were retracted ventrally. A branch of the cutaneous sensory nerve to the 
skin of the neck was encountered superficial to the parotid, running in the same vector as the  
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Figure 5. 
Intraoperative photographs of the posterior auricular nerve (PAN) in a mouse 
 
 
The image on the left shows the animal in the right lateral position with the ear folded forward 
and the operating area depilated. On the right the skin incision has been made exposing the 
parotid gland. 
 
 
Figure 6. 
Intraoperative photographs of the surgical approach to the PAN in a mouse 
 
 
In the image on the left the fluorescent nerves are highlighted against the background tissue 
under the fluorescent dissecting microscope. The posterior auricular nerve has been divided in 
the image on the right. 
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cranial nerve. Since the dissection was carried out cephaladad to the parotid through a small 
incision care must be taken not to mistake this for the PAN. In YFP animals this nerve is often 
less intensely labeled with fluorophore. The branches of the PAN can be seen arising deep in the 
neck medial to the parotid gland, which must be retracted, and clearly coursing onto the posterior 
aspect of the concha. By following the terminal nerve branches caudally they can be seen to 
coalesce and run as a single nerve in the lateral neck towards the skull. This is where the nerve is 
large enough to effect a repair or graft. 
 
Animals were divided into 3 surgical groups: 
a) In the nerve cut group (C) the nerve was divided and the wound was closed (Fig 6). It 
was noted that in some of the animals in the twelve week nerve cut group a degree of 
reinnervation of the distal nerve was observed. Examining the site of nerve division a large 
neuroma was evident (Fig 7). Some axons had crossed the division site and where the axons had 
encountered the distal stump they reorganized and fasiculated. As a result the method was 
adapted to make the control more robust. The nerve was still divided but more distally and the 
proximal stump was mobilized sufficiently to bring it superficial to the parotid, thus interposing 
the gland between the two cut ends of the nerve.  
 
b) In the nerve repair group (R) the nerve stumps were approximated with a single 11/0 
nylon suture (S&T AG, Neuhausen, Switzerland) through the epineurium. This provided 
adequate approximation of the cut ends (Fig 8). More than one suture frayed the fascicles like a  
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Figure 7. 
Two photon microscope montage of a neuroma in a nerve cut mouse (pilot methodology) 
 
 
This image shows a neuroma in continuity in a nerve cut specimen, twelve weeks after the intervention (original protocol). The axons 
form a helical structure as they “seek” the distal stumps. Once the axons have reached the distal stumps (top right) they again assume a 
tight fasciculated bundle. 
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Figure 8. 
Intraoperative photographs of a surgical repair in a mouse 
 
 
Here the divided stumps of the posterior auricular nerve have been opposed with a single nylon 
11/0 suture. 
 
 
 
horse tail, leaving the nerve ends more disrupted than with no sutures at all. The parotid gland 
was then repositioned over the repair and the wound closed. 
 
c) In the nerve graft group a section of the saphenous nerve was harvested before the 
exposure of the muscles in the neck. With the animal supine the ventral hind leg was depilated 
and prepped with 70% alcohol. A longitudinal incision exposed the ventral neurovascular bundle 
(Fig 9). 
 
The saphenous nerve was dissected away from the adjacent blood vessels and divided 
proximally. A single 11/0 suture was placed in the distal stump (outside to inside) and left untied. 
The distal nerve was then divided so that 5mm of graft could be removed suspended on this 
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suture and placed in Ringer's lactate solution [manufacturer] until the neck was prepared. This 
prevents the graft from drying out. The wound in the leg was closed. 
 
Once the nerve in the neck had been exposed and divided the graft was reversed and placed in 
situ in the space the gap between the nerve ends. The suture in the graft was then passed through 
the proximal nerve stump (inside to outside) and secured. A second suture was placed between 
the distal end of the graft and the distal nerve stump (Fig 10). Finally the parotid gland was 
repositioned and the wound closed. This added 5mm to the length of the distal nerve in the 
grafted group, increasing the distance axons had to regenerate to reinnervate the muscle. This 
does potentially affect our ability to compare the repair and graft groups at the three time points 
as the distances are not equivalent. Given the very small length of PAN in the lateral neck before 
it starts to branch into multiple terminal nerves, this was unavoidable. We decided that it was 
acceptable given the speed with which the nerves had regenerated after nerve repair or graft in 
the pilot studies. 
 
All skin wounds were closed with 6/0 nylon sutures (Ref: 911B, Angiotech, Reading, 
Pennsylvania, USA) and the animals revived with Antisedan (atipamezole hydrochloride 0.25 
mg/ml, Pfizer, New York, USA). Two doses of buprenorphine (0.08 mg/ml, PharmaForce Inc. 
Hilliard, Ohio, USA) were given in the first twenty four hours post surgery and the animals 
monitored for four days as per the Harvard University protocol approved by the Standing 
Committee on the Use of Animals in Research and Teaching (IACUC, USA). 
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Figure 9. 
Intraoperative photographs (mouse) and anatomical drawings (rat) of the nerve graft donor site 
 
 
 
In the surgical images above an incision in the ventral lower limb exposes the neurovascular 
bundle in a mouse. Below is an anatomical drawing illustrating the saphenous nerve in a rat, 
which was used as the donor nerve graft (3).  
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Figure 10. 
Intraoperative photographs of a nerve graft in a mouse 
 
 
 
 
A section of saphenous nerve is secured by an 11/0 nylon suture to the proximal stump of the 
posterior auricular nerve. It is then sutured to the distal stump to bridge the defect as a nerve 
graft.  
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2.7 Perfusion and specimen harvest 
At the time of euthanasia animals were sedated with sodium thiopental at 5mg/20g body weight. 
The ventral thorax was depilated with Nair (Church and Wight Co. Inc., Princeton, New Jersey, 
USA) and prepped with 70% alcohol. Incisions were made from the xiphisternum along both 
sides of the thorax in the mid lateral line to expose and divide the ribs in a shield shape. This 
provided access to the medastinum and heart. A cut was made in the right ventricle to allow 
blood to vent. A 5ml syringe of ice cold Ringer's lactate was slowly perfused through a 30 gauge 
needle to empty the vascular system of blood.  This was then repeated with 5mls of ice cold 4% 
paraformaldehyde (PFA) in 4% phosphate buffered solution (PBS). 
 
The skin of the dorsal neck and head was then depilated and prepped as before and a sagittal 
incision made in the dorsal head and neck that could be extended laterally caudal to the ears. The 
entire right and left interscutularis muscles were harvested en bloc with attached nerves back to 
the point of entry with the skull. In all intervention groups the contralateral muscles and nerves 
acted as an additional control. They were harvested in the same way as the intervention side 
simultaneously and put through the same immunohistochemical protocols. In the interscutularis 
the two sides of the muscle are contiguous, the central fibres interwoven without an aponeurosis, 
allowing the entire construct to be removed en bloc as a single tissue complex.  
 
The muscle-nerve complex was post-fixed in 4% paraformaldehyde (PFA) for 30 minutes on a 
rocking platform protected from light and then washed twice in phosphate buffered saline (PBS) 
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for a total of 60 minutes. The complex was then manually cleared of excess fat and connective 
tissue in a 4% PBS bath before being put through immunohistochemical protocols. 
 
The complex was incubated in bungarotoxin (5µg/ml Invitrogen Corp., Carlsbad, CA, USA) for 
30 minutes on a rocking platform protected from light. Alexa 594 bungarotoxin was used for all 
YFP mice unless otherwise stated. The tissue was then washed twice in 4% PBS for 60 minutes 
total. Finally the tissue complex was immersed overnight in Vectashield (Vector Laboratories 
Inc., CA, USA). Vectashield is glycerol-based and partially dehydrates the muscle, replacing 
some of the water within the tissue, though sufficient water remains to allow the fluorophores to 
function. The glycerol changes the refraction index of the tissue to bring it into line with the slide 
cover slip and also increases the transparency of the muscle fibres which improves the imaging 
on intramuscular structures such as the neuromuscular junctions. 
 
The tissue complex was finally mounted on glass slides using Vectashield as a mounting 
medium. It is optically clear and has both anti-fading and anti-bleaching properties reducing the 
loss of signal from fluorescent proteins during laser imaging. Care was taken to make sure that 
muscle was unraveled and as flat as possible with the nerve arranged orthogonally to the muscle 
in imitation of the natural in vivo scenario. The bilateral interscutularis/nerve complex could be 
mounted on a single slide. This measure enabled the nerve to be traced back to the repair or graft 
during imaging which ensured that the correct side of the muscle was identified in each case. In 
addition, during imaging, the proximal (intervention) and distal (muscle) ends of the nerve could 
be reliably identified. 
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Glass cover slips of 1.0mm thickness were used, to reduce optical refraction during imaging. 
Magnets were placed on top of the glass cover slips for 20 minutes to compress the muscle and 
provide a flatter specimen for imaging. The cover slip was then sealed with nail varnish and 
stored at -20ºC.  
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2.8 Myelin labeling 
The natural fluorescence in YFP-16 and YFP-H animals only labels the axoplasm of the nerves. 
To identify the presence of a myelin sheath required an immunohistochemistry approach. Myelin 
Basic Protein was labeled according to the following protocol: 
- Forty eight hours in a starting block of 1% Triton X-100 (Sigma-Aldrich, St Louis, 
USA), 4% bovine serum albumin (BSA) , 5% normal goat serum and 0.1% sodium 
azide. 
- Three days in the primary antibody in fresh starting block (1:400), Rabbit-anti-
Human Myelin Basic Protein (AbD setotec, Morphosys UK Ltd, Oxford, UK) 
- Three hours wash in PBS 
- Twenty four hours in secondary antibodies (1:500), 594 Goat-anti-Rabbit (AbD 
serotec, Oxford, UK) 
- Three hours wash in PBS 
Samples were then remounted on glass slides in Vectashield (vide supra). 
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2.9 Image Capture 
Confocal microscopy 
Samples were imaged on a confocal microscope (Olympus FV-1000MPE) using a 20X oil 
immersion optical objective (1.35 Å, 0.8 NA) and excited by 488nm and 568nm lasers through a 
dichroic mirror (440/488/568/633 nm). Emission light was divided into two channels. The first 
by a dichroic mirror at 560nm and then through a filter at 505-550 nm, the second by a mirror 
and then a filter at 575-675nm. Channels were sampled sequentially with twice Kalman 
sampling. Scan speed, laser power, gain and offset were all optimised for resolution with 
minimal bleaching. Images were captured at 1024 by 1024 pixels which corresponds to an image 
size of 635.283µm². 
 
The intervention and control sides of the muscle were imaged in one session as a series of stacks 
using the montage settings of the Olympus software. Each stack was independently arranged to 
encompass the upper and lower limits of the axons and neuromuscular junctions at a slice 
thickness of 0.70µm. 
 
Montages were taken in a single channel (488nm laser) at 20X (1.35 Å, 0.8 NA) of the nerve 
from the point of repair through to the point of entry into the muscle. This was done in both 
YFP-16 and YFP-H animals. 
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Myelin antibody labeling was imaged on the same microscope using a 60x oil immersion 
objective (1.35 NA). The same laser lines and dichroic filters were employed as described above. 
Z slice thickness was set at 0.37µm to ensure over-sampling and maximum resolution. 
 
Two photon microscopy 
 
 
To obtain images of axons with a high enough resolution in 'Z' samples were imaged using a two 
photon microscope (Zeiss, 710 NLO, Axio Examiner microscope). Stacks were taken of the 
proximal and distal ends of the terminal branch of the PAN to the interscutularis for both 
intervention and control samples. A 950nm excitation laser was used through a dichroic filter. 
The emission light was streamed through a 525-560nm filter. Images were taken using a 63x oil 
immersion optical lens (1.45 NA) with a slice thickness of 0.38µm to acquire maximum Z 
resolution. Scan speed, laser power, gain and offset were all optimised for resolution even at the 
expense of some bleaching. Images were captured at 828 by 828 pixels, which corresponds to an 
image size of 134.79µm². 
 
  
	 73	
2.10 Image processing 
Neuromuscular junctions 
Each confocal stack was opened in ImageJ (256). Each channel was then assigned an appropriate 
colour: nerves green and neuromuscular junctions red (Image; Color; Channels Tool: Select 
color from drop down: Assign colours to each channel: Select composite from dropdown). A 
maximum intensity projection was then generated (Stacks; z-project: maximum intensity) and 
saved as a tiff file. All the maximum intensity tiff files for a given muscle's montage were then 
stitched together in Adobe Photoshop CS5.1 (Adobe Systems Inc., CA, USA) to create a single 
montage of the entire neuronal arbor. Each image (now a layer) was adjusted for gamma in red 
and green to standardise the background across the whole montage.  
 
The junctions were counted and measured in ImageJ from the stitched montage with the Region 
of Interest tool (Analyze; Tools; ROI manager) using a tracing tablet and stylus (Wacom Cintix 
12WX, Wacom Co, Ltd, Vancouver, WA, USA). At 150% zoom the circumference of each NMJ 
was traced with the freehand selection tool and the outline adjusted to an ellipse (Edit; Selection; 
Fit Ellipse). This was measured (Add. nb: the Show all box of the ROI manager should be ticked 
to prevent double counting). Once all the junctions have been measured the data can be collated 
(ROI manager; measure) and the results copied to an Excel (Microsoft Office 7 Professional) 
spreadsheet. This provides both a numerical count of all the junctions, and measures their cross 
sectional areas (Fig 11). 
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Figure 11. 
Region of Interest (ROI) tool to count and measure the number and area of neuromuscular 
junctions 
 
Counting of neuromuscular junctions that are double-labeled with alpha-bungarotoxin and YFP 
fluorophore using the ROI tool which avoids errors through double counting. Each junction is 
numbered, and then encircled using an ellipse tool to estimate cross sectional area. 
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Axonal load 
Each terminal nerve to interscutularis was sampled at two points: its most proximal and distal 
extent. Each two photon stack was opened in ImageJ. The stack was scrolled through to locate an 
area where the nerve was most clearly resolved and ran straight. A line was drawn orthogonal to 
this area using the line tool and a perpendicular stack created (Stack; Reslice) of 100 slices. This 
gave a digital reconstruction of 100 cross sections at a separation of 0.38µm. This stack was 
saved as a NIFTI file. 
 
The NIFTI file was opened in itk-SNAP (www.itksnap.org) and a 5 consecutive slice section 
selected for tracing (257). For tracing each axon was given a different designated colour (Label 
editor; new) and a single operator (A. Woollard) traced the outline of each axon in each slice. 
The tracing was performed using a Cintiq 12WX interactive tablet, as above. The axonal volume 
data (Segmentation; Volumes and statistics) was copied to an Excel file (Microsoft Office 7 
Professional). 
 
Myelin 
 
 
Stacks were opened in ImageJ and translated as described above. In this case axons were 
assigned red and myelin green to improve clarity. Stacks were scrolled through in an XY plane 
and in Z as a reslice to ascertain the presence of a myelin sheath. 
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Axon branching 
Axonal branching was analysed in two ways: 
- measuring the change in axon number between proximal and distal cross sections in YFP-16 
animals. 
- tracing individual axons in YFP-H animals in a montage of the nerve. This was done in Adobe 
Photoshop CS5.1 (Adobe Systems Inc., CA, USA). 
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2.11 Statistics 
Almost all the data sets were analysed using a two way ANOVA test. In addition paired T tests 
and one way ANOVA were used to analyse some the data in the control population. A number of 
statistical software programs were used: PRISM 6 (GraphPad Software Inc., La Jolla, CA, USA) 
and SigmaPlot (Systat Software Inc., San Jose, CA, USA), and SPSS (IBM, UK). Significance 
was set as a P value of less than 0.05.  
 
All the data sets failed the Kolomoglov-Smirnoff test for normality. Khan and Mendes have 
shown that despite the lack of normality, a two way ANOVA was the most appropriate statistical 
test in this scenario (258-260). Tukey’s test was used for post hoc comparison of each variable to 
ascertain significance between time periods and between interventions. 
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3.  
The normal pattern of innervation in the interscutularis 
muscle 
 
3.1 Introduction 
 
This study aims to model the scenario of facial reanimation where a functional muscle transfer is 
reinnervated by a terminal branch of the facial nerve through a nerve graft. The goal is to analyse 
the patterns of reinnervation in a muscle after nerve repair and nerve graft. Elucidating changes 
that occur in the nerve and the muscle and how they interact will provide information about the  
deficits  encountered in clinical reinnervation scenarios.  
 
To understand the deficits however, it is first necessary to characterize the relationship between 
nerve and muscle in an uninjured control. A requirement of the selected model is that the muscle 
be innervated by a cranial nerve, as Macquillan and colleagues demonstrated the peripheral and 
cranial nerves have different capabilities of reinnervation (261,262). The muscle selected for this 
study was the interscutularis in a mouse. This is a muscle on the dorsal aspect of the head that 
moves the ears and its neural arbor has previously been characterized in detail (263,264). The 
muscle is thin and flat making it possible to image the entire muscle and its neural arbor. 
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Interscutularis is innervated by a terminal branch of the posterior auricular nerve, itself a branch 
of the facial nerve. A further advantage is its anatomical location as it is possible to operate on 
the nerve in the lateral neck without disturbing the tissues around the muscle, therefore reducing 
scarring that may interfere with subsequent imaging. 
After injury to a peripheral nerve there is a loss of function of the muscle-nerve complex. The 
distal nerve segment undergoes Wallerian degeneration (265). The proximal segment dies back 
to the last node of Ranvier. The glial Schwann cells dedifferentiate and convert to a form that 
supports axon growth through their empty Büngner’s bands. Myelin sheaths disintegrate and the 
debris is phagocytosed. The absence of depolarizing supra threshold potentials at the 
neuromuscular junctions effectively leaves the muscle stranded with no stimuli. Unable to 
contract, the fibres atrophy and the receptor plaques are reabsorbed over time. 
 
The proximal axons begin the process of regeneration by resuming their developmental state. 
Growth cones form and seek the distal stump endings to their target organ, in this case the 
muscle. The nature of the injury has an impact on the ability of axons to return to their 
appropriate distal course. Nguyen has shown that after a nerve crush the original configuration of 
branching is restored 93% of the time (103). If there has been a total axotomy with disruption of 
the proximal-distal continuity the accuracy of reinnervation is greatly reduced. The reoccupation 
of synapses by their original axons can be used as a marker for the accuracy of reinnervation. 
This dropped from over 90% in nerve crush to less than 5% after nerve cut (103). Two factors 
are often cited to contribute to the disruption: axon loss and axon misdirection. Some axons get 
stuck in the neuroma at the site of injury and fail to enter the distal stumps, not contributing to 
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the reinnervation (Fig 12).  Of the axons that do enter the distal stumps many are unlikely to 
enter their previous endoneurial tubes. This mismatch results in axons occupying different 
synapses on the target muscle and leading to a new branching pattern. Axons have several 
strategies to compensate for the reduced number that enter the distal tubes. Axons can divide 
extramuscularly to produce several branches. Intramuscularly axons can produce both collateral 
and terminal sprouts to occupy more synapses. It is thought each axon can effectively increase 
the size of its motor unit by a factor of between four to six (221,222). Subsequent remodeling 
can compensate for the abnormal wiring of the connectome through the pruning of inappropriate 
axon branches. 
 
In clinical neurotomy scenarios a surgical nerve repair attempts to reduce the deficit of the 
injury. This secures the proximal and distal stumps in close approximation aiming to reduce the 
number of axons that escape the distal stump. There was a vogue for fasciular repair but this has 
not been shown to improve results, although alignment of motor and sensory anatomy in mixed 
nerves appears beneficial (266-268). Tension across a repair negatively effects nerve 
regeneration (269-271). If the gap between the two nerve stumps is too great to effect a repair 
without tension, bridging the gap with a graft improves the outcomes (272-274). To date 
autologous grafts have been shown to provide better results than other materials. Cadaveric 
allografts have recently shown some promise, especially since they avoid a donor site morbidity  
(275,276). The use of allograft requires immunosuppression but does offer the potential to graft 
using mixed sensory/motor nerves, which has shown to produce better results in muscle 
reinnervation than the purely sensory donors that autologous grafting is restricted to (277-279).   
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Figure 12. 
Two photon microscope montage a neuroma in a nerve repair mouse 
 
 
A neuroma forming at the site of a nerve repair. The shadow of the suture is visible. Fasciculated 
axons arrive in the donor nerve (right). There is apparent chaos at the site of repair and then 
order is restored as axons re-enter the distal stumps. Some axons do not navigate the site of 
injury and are misdirected into adjacent tissue (upper right). 
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Conduits demonstrate reasonable results in small defects (280). These are materials that provide 
a scaffold tube for the regenerating axons to cross the gap to the distal stump. They can be either 
biological such as arteries, veins and skeletal muscle, or synthetic such as silicone, polyglycolic 
acid polymer, polytetrafluoroethylene, collagen, poly-DL-lactide-caprolactone (281-285). These 
techniques are suitable for very small defects (280). However, any sort of graft introduces an 
extra repair site, as well as a non-vascularised segment of tissue, for regenerating axons to cross. 
Birch showed in clinical cases the regenerating axons sometimes crossed the first repair site but 
stopped advancing within the substance of the graft (272). In a traditional two-stage facial 
reanimation a graft is used to carry the axons of the facial nerve on the functioning side across 
the face to the paralysed side, a distance of 10-14cm. One of the aims of this study was to 
ascertain if there was a difference in the patterns of reinnervation of the muscle between nerve 
repairs and nerve grafts. 
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3.2  Methods 
The main body of this study was conducted using YFP-16 mice that express the yellow 
fluorescent protein in all their peripheral axons. These mice were used to analyse the axons in the 
terminal nerve to the interscutularis. Digital cross sections were taken at the proximal and distal 
end of this nerve providing a count of the number of axons and their caliber (Fig 13). Antibody 
staining for myelin basic protein identified the axons that have reconstituted a myelin sheath. 
The muscle’s neuromuscular junction acetylcholine receptor sites were labeled with a 
fluorescently tagged alpha-bungarotoxin. The junctions have a distinctive pretzel-like 
morphology made up of an end-plate zone that forms a continuous gutter (Fig 14). Each junction 
is distinct, much like a fingerprint, making it possible to use them as fiduciaries  (286).  
 
By using YFP-16 transgenic animals and an alpha-bungarotoxin with a fluorescent label at 
633nm it is possible to excite the two fluorophores separately with different lasers. Innervated 
junctions are double labeled and the signals can be separated to show the terminal axon 
conforming to the shape of the end-plate gutter. This double labeling provided a count of how 
many junctions were innervated and information about the morphology of the junctions (Fig 14).  
 
The normal interscutularis has been characterized previously by Lu et al. in four YFP-16 mice. 
There each connectome had 14.5 ± 1.5 axons supplying 198 ± 11 muscle fibres (junctions). Six 
percent of axons branched within 3mm of the muscle edge but there was no branching seen 
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Figure 13. 
Two photom microscope montage of proximal and distal nerve sampling 
 
The proximal stump of the nerve is seen in the bottom left corner. This has regenerated through a graft and into the distal nerve 
bundles. The terminal branch to interscutularis has been digitally cross-sectioned at two points (proximal and distal) and the number 
and caliber of axons traced and measured. 
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Figure 14. 
Confocal microscope image of axons and double-labeled neuromuscular junction morphology 
	
	 	
In the upper double-labeled image from a control specimen, axons are labeled in green (YFP 
fluorophore) and the neuromuscular junctions in red (alpha bungarotoxin). The lower images 
show the green channel (left) and the red channel (right) separately. Innervated junctions (eg red 
arrow) exhibit the same shape in both channels showing complete occupation of the receptor 
gutter by the axon.  
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between 3mm and 5mm from the edge of the muscle. The mean motor unit size was 7.7 ± 2.8 
fold. The smallest motor unit had just one junction and the largest 37 junctions. Motor unit sizes 
were skewed in favour of smaller units where each axon innervates fewer muscle fibres. Axon 
cross-sectional areas correlated with their motor unit size according to a power law. The area 
scaled to the square root of the motor unit size (252). 
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3.3  Results  
The controls for this current study came from 18 muscles in 9 animals (Fig 15).  They were used 
to characterize the normal muscle and nerve parameters. The mean number of neuromuscular 
junctions in normal muscles was 265.4 ± 32.0 (n=18) (Fig 16). There was variability between 
animals, and between sides in individual animals. The difference between left and right in each 
individual was not statistically significant (P=0.4, paired T test, Fig 17), however the inter-
specimen variability was found to be significant (P = 0.013, one way ANOVA, Fig 18). 
 
As an animal gets older it gains mass (Fig 19) and the cross-sectional area of each muscle fibre 
increases in size (287). The size of each neuromuscular junctions varies with changes in the 
diameter of the muscle fibre it innervates (242). The mean age of the control animals at the time 
of perfusion was 90.4 ± 55.1 days. The mean mass of the animals was 30.4 ± 9.2g. To control for 
the difference in age, and therefore mass, the data was normalized (area for each junction was 
controlled for by animal mass in grams at time of perfusion). The mean size of each junction was 
33.9 ± 7.7 µm2/g. and there was no difference left and right side of the same individual (P = 0.9, 
unpaired T-test, Fig 21) supporting the absence of “handedness” shown in the NMJ numbers. 
The mean total surface area of receptors per muscle is 10040 ± 2872 µm2/g  (n=18) (Fig 20). The 
difference in the mean total surface area between individual control animals was statistically 
significant (P<0.0001, one way ANOVA). 
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Figure 15. 
Confocal microscope image of axonal arbors in a YFP-16 control mouse 
 
 
These are examples of YFP-16 neuronal arbors in control specimens. They have a typical 
branching pattern that enters the end-plate zone of the interscutularis muscle. 
Neuromuscular junctions are labeled red with bungarotoxin. The nerve is labeled with native 
fluorescence by yellow fluorescent protein. In this YFP-16 animal all of the axons are labeled 
and the entire arbor is visualised. 
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Figures 16-18 illustrate the number of neuromuscular junctions in the control specimens, 18 muscles taken from 9 animals. There is no overall 
difference between the number of junctions in right and left muscles. However, in each individual the difference between right and left (each 
side is plotted in fig 18) is significant. 
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Figures 19-21 Junctional area increases linearly with increasing age as the animal’s mass increases. Cross sectional areas were controlled for 
mass. The mean junctional area is unimodal and there is no difference in area between the junctions in right or left muscles. The total 
junctional surface area of muscles is clustered around 10,000µm. 
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Axons 
The number of axons supplying the interscutularis muscle were measured by taking cross 
sections at two points in the terminal nerve to the muscle. These two points were at the proximal 
end of the terminal branch (when all remaining axons are only supplying the interscutularis) and 
at the distal end just as it is about to enter the muscle. There were anatomical variations in two 
animals where the terminal nerve to interscutularis was short. In these cases there was inadequate 
length after the final division of the terminal nerve to acquire proximal axon data. These 
specimens were excluded from analysis. The mean number of axons was 19.6 ± 4.6 proximally 
(n=16), and 23.1 ± 5.8 distally (n=16) (p=0.0002 paired t-test, Fig 22). There was a mean 
increase of 19.7% ± 16.5% in the number of axons over the course of the terminal branch of the 
nerve. This figure encompasses a wide range from 0% to 57.9%. 
 
The mean diameter of axons proximally was 8.0µm ± 1.2µm (n=313) and 7.7µm ± 1.2µm 
(n=393) distally (Fig 23). The total cross-sectional area of axons represents the sum of the 
individual cross-sectional areas of all the axons within a particular nerve. This increased from 
1191µm2 ± 429µm2 proximally to 1325µm2 ± 374µm2 distally (Fig 24). This increase, despite a 
fall in the mean axon diameter as the axons taper distally, was due to the increase in the number 
of axon fibres. 
 
Antibody labeling to myelin basic protein shows that all axons were enclosed in a myelin sheath. 
In a small subset of the two-photon images of nerve there was some fluorescent expression 
within the connective tissue surrounding the axons. In these samples there was bright 
fluorophore expression in the axon and faint expression in the connective tissue. Between the 
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Fig 22-5 illustrate changes that occur in the terminal nerve to interscutularis. There is an increase in the number of axons as a result of 
branching in the terminal nerve to the muscle. The mean diameter of distal axons shows a unimodal distribution around a mean of 7.7µm and 
the total cross sectional area of axons increases as the nerve approaches the muscle. The mean motor unit size (number of neuromuscular 
junctions/number axons) cluster around a mean of 14 NMJ/axon 
Number of axons in the control nerve to interscutularis
at the proximal and distal sampling points 
Proximal Distal
0
10
20
30
40
Control nerves
N
um
be
r o
f a
xo
ns
n=16 n=16
P = 0.0002
Paired t-test
Proximal Distal
0
500
1000
1500
2000
2500
Control nerves
To
ta
l c
ro
ss
 s
ec
tio
na
l a
re
a 
ax
on
s 
µm
2
Total cross sectional area of axons in controls:
proximal and distal sampling points
n=16 n=16
Distal Axon Diameters in Controls
0 5 10 15 20
0
20
40
60
80
Axon diameter/µm
N
um
be
r o
f a
xo
ns
n=393
Mean
Std. Deviation
Controls
7.72947
1.21348
Mean motor unit size in controls
Controls
0
5
10
15
20
25
M
ot
or
 U
ni
t S
iz
e 
ju
nc
tio
ns
/a
xo
n
n=16
Figure 22 Figure 23
Figure 24 Figure 25
	 93	
two there was a dark halo corresponding to the presence of the myelin sheath (Fig 26). 
 
The mean size of the motor units can be calculated by dividing the number of neuromuscular 
junctions by the number of axons that supply the junctions. The increase in axon number in the 
terminal nerve, from proximal to distal, represented branching of the proximal population. 
Whilst the proximal number may have included some branches that have divided more 
cephaledad, it still represents a more accurate estimate of the number of individual axons 
supplying the muscle for the purpose of calculating mean motor unit size. Lu at al. produced a 
“wiring diagram” for four interscutularis muscles in which he traced each axon through to each 
of the NMJ that it innervated. However, whilst this produced an actual size of motor unit for 
each axon, he only picked up the axons 5mm from the muscle edge, essentially our distal 
sampling point. We have shown that there are approximately 20% more axon fibres at the distal 
end of the terminal nerve than at its proximal origin. This suggests that not all of the axons at the 
point where it meets the muscle are isolated individuals. We believe our methodology represents 
a more accurate way of calculating mean motor unit size than the Lu et al. data.  
The number of innervated junctions was divided by the number of axons at the proximal site for 
each muscle. In control muscles the mean motor unit size was 14.0 ± 2.5 junctions/axon (Fig 25). 
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Figure 26. 
Confocal and two photon microscope images of axons showing the presence of myelin sheaths 
	 	
	 		
In the upper images the axons’ native fluorescence is labeled red and antibodies to Myelin basic 
protein are labeled green. Each axon is enclosed in a separate myelin sheath. The lower images 
are taken in a single channel, two photon microscope, that show bright labeling of the axons and 
faint labeling of the connective tissue. The black areas that surround each axon are myelin. 
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3.4  Summary 
The characteristics of the interscutularis muscle are suitable for modeling nerve repair and nerve 
graft in a facial palsy. It is innervated by a cranial nerve, and we know from MacQuillan’s work 
that cranial and peripheral nerves behave differently when re-innervating muscles (288). The 
interscutularis has been used in previous studies analysing both its neural arbor, and its response 
to reinnervation after nerve injury (289,290). The characteristics of the have been further 
elucidated by our control group. The muscle-nerve complex also has certain advantages from the 
methodological perspective. There is a terminal nerve branch supplying the muscle that can be 
accessed easily without disturbing the muscle itself. This allows for surgical interventions 
without producing scarring around the muscle which would interfere with subsequent imaging. 
However, one disadvantage of this system is that the nerve originates within the cranium. This 
means that it is not possible to ascertain how many of the axons at the start of the terminal 
branch are individuals or sub-branches. 
 
In summary the interscutularis is a thin muscle supplied by a terminal branch of the facial nerve. 
It has approximately 265 muscle fibres supplied by 20 axons. This gives a mean motor unit size 
of 14 muscle fibres per axon. At the proximal end of the terminal branch to the muscle the axons 
are a relatively homogeneous population with an average diameter of 8.0µm and all are 
myelinated. Some axons do branch extramuscularly, but the degree of branching is variable 
between specimens. 
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4 
Characterisation of the changes seen in the interscutularis 
muscle after reinnervation through a nerve repair or nerve 
graft in YFP-16 specimens 
 
4.1  Introduction 
A nerve enters a muscle at the end-plate zone, an area rich in neuromuscular junctions. In the 
interscutularis this zone is a well-defined and compact area towards the lateral pole of the 
muscle.  Once the nerve enters the muscle the axons spread out and arborise to cover the end-
plate zone like the branches of a tree. Each axon will contact several junctions, but each mature 
junction is only innervated by a single axon. All of the junctions innervated by the same axon are 
collectively referred to as a motor unit. The arbors of reinnervated muscles closely resemble the 
controls (Fig 27).  
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Figure 27. 
Confocal microscope images of the arbors of YFP-16 mice after nerve repair and nerve graft 
 
 
The arbors of reinnervated muscles twelve weeks after nerve repair (left) and nerve graft (right). They closely resemble the control arbor (Figure 14). 
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4.2  Results 
 
Skeletal muscle fibres are typically innervated at a single neuromuscular junction site. To assess 
the number of muscle fibres remaining after interventions the number of occupied neuromuscular 
junctions were counted in reinnervated muscles (Fig 11). 
 
There was no significant difference between the number of junctions in reinnervated muscles and 
controls at any time period (P=0.37, Two-way ANOVA (Fig 28, Table 4). In the nerve cut group 
(C) where the nerve was divided and a segment removed (nerve cut) there were no reinnervated 
junctions at four, six or twelve weeks (Fig 29).  
 
Table 4 
Mean junction number per group at four, six and twelve weeks. 
Mean ± Standard deviation (n) 
Group/Time 4 weeks 6 weeks 12 weeks Overall 
Repair 263.1 ± 43.2 (9) 303.0 ± 31.7 (9) 261.8 ± 52.1 (9) 276.0 ± 45.8 
Graft 276.3 ± 53.2 (9) 270.0 ± 46.3 (9) 242.6 ± 43.0 (9) 263.0 ± 48.2 
Controls    265.4 ± 32.1 
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Figure 28. 
 
 
 
There was no significant difference in the number of neuromuscular junctions between the 
control group and either of the intervention groups at any time period after reinnervation. There 
is only one junction per muscle fibre so the number of fibres has remained constant.  
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Figure 29. 
Confocal microscope image showing the end plate zone of a nerve cut mouse 
 
 
This double-labeled image is a nerve cut specimen four weeks post intervention. No 
neuromuscular junctions were reinnervated at any time period where the nerve was divided and 
not repaired or grafted. In this image an axon has regenerated into the arbor, but it has not made 
any connections with neuromuscular junctions. This axon has a wavy appearance (also see Fig 
51) unlike the motor axons seen in control specimens and perhaps represents a sympathetic axon. 
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Figure 30. 
Confocal microscope image of axons and labeled NMJ four weeks after a nerve graft 
 
 
This double-labeled image is a nerve graft specimen four weeks post innervation. Terminal axon 
sprouts extend from occupied junctions and innervate small areas of neuromuscular receptor 
labeled with alpha-bungarotoxin (red arrows) that resemble a ‘string of beads’. These areas of 
receptor may represent degenerated junctions, or areas of de novo receptor on denervated muscle 
fibres. 
 
  
	 102	
The surface area of all reinnervated NMJ was estimated using ImageJ and standardised by 
controlling for the mass of each animal at the time of perfusion. The mean NMJ size was smaller 
in the intervention groups than in the controls at all time points. Taking time and intervention as 
variables, two way ANOVA was not statistically significant (p=0.88). However, whilst there was 
no change over time (p=0.816), the difference between the interventions was significant 
(p<0.001). Tukey’s test demonstrates that although the NMJ size in the repair and graft groups 
were not dissimilar (p=0.596), they were both significantly smaller than those in the control 
group (p<0.001). The NMJ increased in size in both repair and graft groups with time from 
intervention but never recovered their original surface area (Table 5, Fig 31). At twelve weeks 
the mean size of NMJ in the repair group is 94% of controls whilst the graft group remained 
smaller at 77%. 
Table 5. 
Mean NMJ size µm2/gram in each of the intervention groups at four, six and twelve weeks. 
Mean ± Standard deviation (n) 
Group/Time 4 weeks 6 weeks 12 weeks Overall 
Repair 30.5 ± 13.6µm2 
(2368) 
25.1 ± 6.3µm2 
(2729) 
31.7 ± 10.9µm2 
(2360) 
28.3 ±6.9µm2 
(7457) 
Graft 22.2 ± 10.7µm2 
(2491) 
25.5 ± 9.3µm2 
(2430) 
26.0 ± 7.0µm2 
(2195) 
25.8 ±10.0µm2 
(7116) 
Cut 26.7 ± 5.3µm2 
(872) 
23.5 ± 6.8µm2 
(152) 
N/A  
Controls    33.9 ± 7.7µm2 
(4775) 
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The mean total surface area of high-density receptor sites per muscle increased over time in both 
intervention groups, but remained smaller than controls at all time points (Table 6).  
Table 6. 
Total NMJ cross sectional area of repairs & grafts at four, six and twelve weeks in µm2/gram. 
Mean ± Standard deviation (n) 
Group/Time 4 weeks 6 weeks 12 weeks Overall 
Repair 6925 ± 1659µm2 
(9) 
7759 ± 1552µm2 
(9) 
7694 ± 2223µm2 
(9) 
7459 ± 1085µm2 
(27) 
Graft 5388 ± 1321µm2 
(9) 
6187 ± 699µm2  
(9) 
6095 ± 1395µm2 
(9) 
5904 ± 1190µm2 
(27) 
Controls    10040 ± 2872µm2  
(18) 
 
Two-way ANOVA of the total NMJ surface areas showed no significant difference between the 
groups (p=0.937). However, whilst the time difference is not significant (p=0.521) the difference 
between the interventions and controls showed the total surface area of receptor to be 
significantly smaller post reinnervation (p<0.001, Fig 32). This significance existed between 
each intervention and controls as well as between nerve repairs and nerve grafts (Table 7). 
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Figure 33
Boxes represent the 25th bto 75th percentiles, whiskers are minimum and 
maximum values. The green dotted line is the mean for all junctions in the 
control group.
The mean cross sectional area of neuromuscular junctions is smaller in all 
reinnervated muscles than controls. The trend is for the mean size of junctions 
to increase the lpnger they have been reinnervated. This is also apparent in for 
the total cross sectional area of junctions/muscle.
Whenr the total crosss sectional area of NMJ is represented as a percentage of 
the controls both interventional groups achieve an asymptote at six weeks. 
The nerve repair group achieve 77% of the area of controls and the nerve 
grafts 61%.
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Table 7. 
Two way ANOVA and Tukey’s multiple comparisons of neuromuscular junction total surface 
areas for nerve repairs and nerve grafts at four, six and twelve weeks post intervention versus 
controls. 
Variables P Tukey’s Test P 
Time 0.521  
Intervention & Time 0.937 
Intervention <0.001 
 Control Vs Graft <0.001 
Control Vs Repair 0.002 
Repair Vs Graft 0.020 
 
The mean total surface area of receptor expressed as a percentage of controls shows that after an 
initial increase in area in both repairs and grafts there was no change between 6 and 12 weeks 
(Fig 33). Values reach an asymptote of 77% for repairs and 61% for grafts. This illustrates that 
the total area of receptors increased after reinnervation but reached a stable state that was less 
than the original surface area. 
 
In the nerve cut group there was no reinnervation of the neural arbor. The NMJ gradually 
diminished in size over time and lost their architecture. At four weeks most NMJ were still 
present with normal morphology but some had already become smoother, losing the intricacy of 
the folds in the gutters. Some NMJ maintained their original architecture even at six weeks post 
denervation but by twelve weeks all recognizable junctions have disappeared (Fig 34). 
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Figure 34. 
Confocal microscope images of the end plate zone in a nerve cut specimen at four, six and twelve 
weeks after division of the nerve 
 
   
4 weeks   6 weeks    12 weeks 
In the upper, double-labeled image of a nerve cut specimen at four weeks post denervation there 
is no reoccupation of the arbor. A single axon has grown back along the terminal nerve and is 
seen crossing the muscle from right to left. It has a wavy appearance unlike the motor axons seen 
in control specimens and perhaps represents a sympathetic axon (see Fig 51). 
The nerve cut specimens (four, six and twelve weeks) show a gradual atrophy of the NMJ with 
prolonged denervation. The number of recognizable NMJ reduces over time, and their size also 
shrinks. By twelve weeks there are only fragments of NMJ persist. 
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4.3 Summary 
 
 
In summary the number of neuromuscular junctions remained constant in both the nerve repair 
and nerve graft groups compared to controls, which suggests that there was no loss of muscle 
fibres. The mean size of the NMJ was smaller after intervention (repair or graft) compared to 
controls, and though they enlarged with time they stabilized at a smaller size. The mean total 
surface area of receptor sites increased between four and six weeks but remained stable 
thereafter. The repair group recovered more receptor area than the graft group. Both groups 
regained more than the 20% of receptor area that Wood suggested is the minimum required for 
normal neuromuscular transmission (300). On balance it appears that the innervation parameters 
of the muscle have been restored after both repair and graft. 
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5. 
Characterisation of the changes seen in the terminal nerve to 
the interscutularis after reinnervation through a nerve 
repair or graft in YFP-16 specimens 
 
5.1 Introduction 
The characteristics of a muscle are dependent on a ratio between the numbers of muscle fibres 
and the axons that innervate the muscle. In the previous chapter it was demonstrated that the 
number of muscle fibres remains constant with reinnervation through either a nerve repair or 
nerve graft. Nguyen showed that after a nerve crush axons recapitulate their original patterns 
extremely accurately (103). However, this was not the case after nerve cut. Here the aim was to 
analyse the patterns seen after nerve repair and nerve graft. It is perhaps intuitive that after a full 
nerve cut there will be a complete disruption of the axons between the proximal and distal 
stumps. Even with accurate apposition of the cut ends reinnervation cannot be perfectly restored 
as prior to the injury. Scar tissue forms at the site of injury which can disrupt the ability of axons 
to locate the appropriate distal pathway (Figs 12 & 35).  Axons that manage to enter the distal 
Büngner’s bands are unlikely to precisely find their original distal path and therefore be 
delivered to their previous target muscle fibres. Axons have been shown to increase their field of 
influence to compensate for axons that no longer innervate the target (221,222). Remodeling has 
been shown to be a powerful tool in manipulating this misalingment (94,95,296). The aim of this 
study is to analyse the patterns and morphology of the axons that re-innervate the muscle after 
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nerve repair of graft. We have shown in normal controls that there is a homologous population of 
myelinated axons innervating the interscutularis that have a consistent diameter of 8µm 
throughout their course in the terminal nerve. All of these axons make connections with motor 
end-plates so can be assumed to be motor axons. Lu has demonstrated that the interscutularis has 
no spindle fibres which further confirms this finding (252) (personal communication with JW 
Lichtman). 
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Figure 35. 
Two photon microsope montage of the PAN after a nerve graft 
 
This is a montage of stacks of a nerve graft specimen six weeks post intervention from a two-photon microscope. The graft, with a repair at its 
proximal and distal extent, is seen in the bottom left. The terminal nerves are included through to the beginning of the arbor at the top right. 
	 111	
5.2 Results 
 
The number and size of regenerating axons were measured at two locations: the proximal and 
distal ends of the terminal branch to interscutularis. These points were both distal to the site of 
surgical intervention. Antibody labeling of myelin basic protein was used to assess whether the 
axons were myelinated. The n values for the proximal and distal sampling points were not equal 
due to anatomical variations in the branching of the terminal nerve to interscutularis. 
Occasionally the final branch to the muscle would occur very late which did not allow for a 
proximal sampling point (Table 8). The four muscles (two repairs at four weeks, one repair at six 
weeks, one repair at twelve weeks) that do not have a proximal sample were excluded from 
subsequent calculations of branching or motor unit size (see below).  
 
Table 8. 
Number of specimens in each group proximally and distally 
Group Experimental Specimens Total Proximal Sampling Distal Sampling 
Controls 18 14 17 
Repair 4 weeks 9 7 9 
Repair 6 weeks 9 8 9 
Repair 12 weeks 9 8 9 
Graft 4 weeks 9 9 9 
Graft 6 weeks 9 9 9 
Graft 12 weeks 9 9 9 
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The mean number of axons (Table 9) for both interventions at each time period was greater than 
controls. 
Table 9. 
Mean axon numbers for repairs and grafts at four, six and twelve weeks. Mean ± Standard 
deviation (n) 
  Weeks Proximal Axon Number 
Mean    (S.D., n) 
Distal Axon Number 
Mean    (S.D., n) 
Controls  19.6 ± 4.6 (16) 23.1 ± 5.8 (16) 
Repair 4 34.7 ± 9.8 (7) 51.7 ± 16.3 (7) 
6 34.3 ± 8.3 (8) 45.9 ± 10.2 (8) 
12 28.0 ± 10.5 (8) 29.1 ± 9.3 (8) 
Graft 4 29.8 ± 9.8 (9) 38.0 ± 11.1 (9) 
6 25.9 ± 6.9 (9) 35.3 ± 10.9 (9) 
12 29.0 ± 6.9 (9) 40.7 ± 18.1 (9) 
 
The mean number of axons in the nerve where it entered the muscle (distal) was significantly 
greater in nerve repairs [43.7 ± 15.4 (n=27)] and in nerve grafts [37.9 ± 13.5 (n=27)] than 
controls [23.1 ± 5.8 (n=16)] (P=0.004, two way ANOVA, Fig 36). The significance of the mode 
of intervention (p<0.001) was much stronger than time (p=0.055). Breaking down the results 
(Tukey’s test) there was no significant difference between the graft groups at any of the time 
points. In the repair group the change between the four and twelve week points was significant 
(p<0.001), with at first an increase and then a decrease in axon numbers. This demonstrates 
remodeling over time. This trend was reinforced when comparing the repairs and grafts against 
controls (Table 10). The grafts remain significantly different from controls throughout the time 
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frame whilst the repairs trend towards the controls, and by 12 weeks are no longer significantly 
different in axon number. 
 
Table 10. 
 Tukey’s comparison of axon numbers in the distal nerve after nerve repair or nerve graft over 
time with controls (p values) 
Comparison/weeks 4 weeks 6 weeks 12 weeks 
Repair Vs Control <0.001 <0.001 0.062 
Graft Vs Control 0.003 0.014 <0.001 
Repair Vs Graft 0.003 0.184 0.254 
 
The mean number of axons at the proximal sampling point [Repairs: 32.9 ± 8.5 (n=23); grafts: 
28.2 ± 7.9 (n=27); controls 19.6 ± 4.6 (n=16)] displayed a slightly different pattern (Fig 37). Two 
way ANOVA was not statistically significant (p=0.577). Whilst there was no change associated 
with time (p=0.319), the difference between each of the interventions was significant (p<0.001). 
Pairwise multiple comparison (Tukey’s test) showed that both interventions were significantly 
different from the controls (p<0.001), but not from each other (p=0.073). 
 
The total number of proximal axons possibly represents a combination of axons and their 
branches. Since no axons join the nerve in this terminal section the increase in axon number 
between the proximal and distal counts represent branching of the proximal group.  Due to the 
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Figures 36 and 37 illustrate the change in the number of axons at the proximal (37) 
and dsiatl (36) sampling points at 4, 6 and 12 weeks post reinnervation. At both 
sampling points and at all time points the number of axons in the intervention 
groups is greater than the control group. Distally the number of axons in the repair 
group reduces over time and this is significant (p<0.001, Tukey's test, from two 
way ANOVA).
Figure 38 illustrates the percentage change in axon number from proximal to distal 
(i.e. branching). In the repair group the degree of change falls over time. This does 
not occur in the graft group.
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considerable variability in total axon numbers between specimens the degrees of branching were 
normalised as a percentage change proximal-to-distal (Fig 38). A comparison between nerve 
repairs, nerve grafts, and controls showed significant difference in percentage change (P=0.007, 
two way ANOVA). The percentage change in the graft group did not change with time. 
However, in the repair group the percentage increase in axons numbers (i.e. branching) fell over 
time. Whilst there was no difference between four and six weeks in the repair group the change 
between six and twelve weeks was significant (p=0.013) and that difference was even stronger 
when comparing the four and twelve week points (p<0.001).  
 
The percentage change in the graft and repair groups diverge significantly over time (P= 0.01, 
linear regression, Fig 39) which supports the idea that the repair group is undergoing a change 
that is not occurring in the graft group. The fall in percentage change and the overall reduction in 
the number of distal axons possibly represents the pruning of axons that did not successfully 
innervate distal targets (94,95). The percentage change in axons in the graft group remained 
constant over time suggesting that whatever process was occurring in the repair group was not 
replicated in the graft group.  This may reflect a lack of remodeling of the axons in the graft 
group. 
 
Axon diameters were measured at the proximal and distal locations (Fig 13). In both intervention 
groups the mean diameter of axons increased over time (Table 11). In addition the mean 
diameters increased from proximal to distally but did not achieve the mean of the control group 
at either position (Fig 39). The mean diameters of axons in the repair and graft groups were 
smaller than the control group both proximally and distally. In the intervention groups there are   
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Table 11. 
Axon Diameters proximally and distally in repairs and grafts compared to controls. Mean ± 
Standard Deviation (n) 
 Weeks Proximal Diameter µm Distal Diameter µm 
Control  8.0 ± 1.2 (313) 7.7 ± 1.2 (393) 
Repair 
4 4.2 ± 1.8 (243) 3.9 ± 1.5 (489) 
6 4.3 ± 1.4 (273) 4.5 ± 1.3 (394) 
12 5.6 ± 1.7 (239) 6.5 ± 1.6 (295) 
Graft 
4 3.7 ± 1.4 (268) 4.4 ± 1.3 (342) 
6 4.4 ± 1.6 (233) 5.3 ± 1.8 (318) 
12 4.9 ± 1.6 (261) 4.9 ± 1.9 (365) 
 
Figure 39. 
 
 
In both repairs and grafts the mean diameters of axons increase over time, at both sampling 
points. However, they never achieve the diameters of the control axons.In the grafted group the 
mean diameter of distal axons reaches asymptote at six weeks.  
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more axons per muscle, but the axon fibres were smaller than those in the control group. The 
axons in the intervention groups gradually increased in size over time. Two way ANOVA 
comparing intervention and time was not significant, either proximally or distally (Table 12). 
However, the intervention variable was significant at both sampling points (p<0.001). 
Table 12. 
Two way ANOVA and Tukey’s test of axon diameters comparing controls with nerve repairs 
and nerve grafts over time (p values). 
Source of Variation Proximal p value Distal p value 
Intervention <0.001 <0.001 
Time/weeks 0.116 0.163 
Intervention * Time 0.452 0.130 
 
All pairwise multiple comparison analysis (Tukey’s test) of the interventions shows that both 
repairs and grafts are significantly different from controls, but not from each other, proximally 
and distally (Table 13). 
Table 13. 
Two way ANOVA and Tukey’s test of axon diameters comparing controls with nerve repairs 
and nerve grafts (p values). 
Comparison Proximal p value Distal p value 
Controls Vs Repairs <0.001 <0.001 
Controls Vs Grafts <0.001 0.163 
Repairs Vs Grafts 0.490 0.759 
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Figure 40 
 
 
 
In controls there is an even, unimodal distribution of axon diameters around a mean of 7.7µm. In both interventional groups there are a large 
number of much smaller axons and the histograms are skewed towards the small calibre fibres. In both repairs and grafts the diameters increase 
but they remain small and skewed towards the left. 
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The diameters of control axons ranged from 3.1µm - 17.7µm proximally and 2.1µm - 14.8µm 
distally. At 4 weeks after repair or graft there was a large population of axons with diameters less 
than 2.5µm. This population was apparent both proximally and distally. Histograms of axon 
diameter were skewed to the left with very few axons greater than 8µm in diameter. The 
population of small axons diminished over time and the means of both the interventional groups 
increased between four and twelve weeks (Fig 40). In the grafted group there was a small 
number of axons at four and six weeks with large diameters (20-30µm) that were not present at 
twelve weeks. These large axons were not present in the repair group at any time. 
 
The total cross section of all the axons innervating the muscle gives a measure of the innervating 
capacity of the nerve independently of whether the axons are individuals or sub-branches. In 
both intervention groups, at all time periods, the total area of proximal axons remained smaller 
than controls (Fig 41). Two way ANOVA was not significant (p=0.611), however the difference 
between the intervention groups was (p<0.001). Tukey’s test shows the total axon surface area 
was larger than both repairs (p=0.008) and grafts (p<0.001) and that grafts were smaller than 
repairs (p=0.011). The total area of axons in the repair group initially fell between 4 and 6 weeks 
then increased again at 12 weeks. In the grafted group there was a steady increase from 4 to 12 
weeks but the areas always remained smaller than the repair group, and the controls.  
 
Distally there was no difference (two way ANOVA) in total axon area between controls and 
either repairs or grafts at any time period (p=0.557). The total areas appeared more stable than 
the proximal sampling point (Fig 42). The repair groups did show a very slight increase over 
time whilst the graft group increased between 4 and 6 weeks and decreased again towards 12 
weeks.  
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Figure 41 
 
 
Figure 42 
 
 
Two way ANOVA of total axon cross sectional area of repairs, grafts and controls was not 
significant at either the proximal (fig 41) or distal (fig 42) sampling points over time. However, 
Tukey’s test showed that proximally the difference between both controls and either repairs 
(p=0.08) or grafts (p<0.001) was significant, and that grafts were smaller than repairs (p=0.01).  
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In the control specimens the total cross sectional area of axons increased by 11% proximal to 
distal whereas the number of axons increased by 19.7% (Table 14). The increase in axon number 
was greater than the increase in cross sectional area suggesting that each axon divides and tapers 
towards the muscle. This relationship was also seen in the repair group at four weeks. There was 
a large increase in axons but minimal increase in area. By six weeks this was reversed and the 
increase in area was larger than the increase in axon number, a trend that was even more 
apparent at twelve weeks. This suggests that the axons were increasing in size towards the target 
organ and smaller axons were being pruned. In the graft group the increase in diameter was also 
greater than the increase in axon number over time. However, the trend is the reverse of the 
repair group over time. At four and six weeks the increase in cross sectional area was far larger 
than the degree of branching. At twelve weeks the degree of branching had increased (to a 
percentage similar to that in repairs at four weeks) and the increase in cross sectional area had 
lessened. Neither group (repair or graft) achieved the proportions identified in the control group. 
This ongoing change may represent remodeling and pruning of axons. However, the timescale 
for remodeling is not clear. The total cross sectional area seems stable in the repair group from 
six weeks whilst it continues to change in the graft group. In both groups the percentage change 
in axon numbers is still evolving at twelve weeks. 
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Table 14. 
Percentage change in total cross sectional area and axon number from proximal to distal in 
repairs and grafts at four, six, and twelve weeks, and controls. 
 Controls Repairs Grafts 
 CSA Axon No. CSA Axon No. CSA Axon No. 
Controls 11.3% 19.7%     
4 Weeks   7.5% 49.0% 114.0% 27.5% 
6 Weeks   38.3% 33.5% 115.7% 36.3% 
12 Weeks   34.5% 3.9% 41.4% 40.3% 
 
 
Mean motor unit size was calculated by dividing the number of neuromuscular junctions by the 
proximal number of axons. There was branching between the proximal and distal ends of the 
terminal nerve so using the proximal axon number as the denominator gives an accurate 
representation of motor unit size than the distal number. Two way ANOVA comparing 
intervention groups with controls was not significant (p=0.568) for both intervention and time. 
The mean motor unit sizes in both intervention groups (Repairs 8.9 ± 2.8 junctions/axon; Grafts 
10.4 ± 4.7 junctions/axon) were significantly smaller than the control group (14 ± 2.5 
junctions/axon; p<0.001). However, there was no significant difference between the two 
intervention groups (p=0.217). This suggests that each axon innervates a smaller number of 
junctions in the intervention groups than in the control group. In the repair group the size of the 
motor units increased over time (Fig 43). The graft group showed an initial increase followed by 
a decrease but the trend was one of motor unit size reducing in size (Table 15). 
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Table 15. 
Mean motor unit sizes for both intervention groups at four, six and twelve weeks and controls. 
Mean ± Standard Deviation (n) 
Time/Groups Repairs junctions/axon Grafts junctions/axon 
4 weeks 7.8 ± 1.7 (7)  10.8 ± 5.7 (9)  
6 weeks 9.4 ± 2.5 (8)  11.5 ± 5.3 (9)  
12 weeks 9.3 ± 3.7 (8)  9.0 ± 2.9 (9)  
 
 
Figure 43 
 
 
Two way ANOVA showed no difference between the mean motor unit size in controls and either 
intervention group. However, the mean motor unit sizes were smaller than controls for both 
interventions at all time points. The trend over time shows the number of motor units increasing 
in the repair group and decreasing in the graft group. 
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Labeling of myelin basic protein was identified around all axons in both the repair and graft 
groups at twelve weeks. In most specimens there were some empty myelin tubes that had not 
been reoccupied by regenerating axons (Fig 44). In a few cases where several small axons were 
very close together it was not possible to achieve sufficient resolution to elucidate whether they 
were in separate sheaths. In one animal the connective tissue fluorescence (vide supra) in some 
control specimens was present. In this case several small axons were shown occupying a single 
myelin sheath (Fig 45). This is consistent with the literature and probably represents multiple 
branches of a common axon within a single sheath (301).  
  
	 125	
Figure  44. 
Confocal microscope images of myelin basic protein immunofluorescence in nerve repair and 
nerve graft mice 
	
	 	
In these double-labeled confocal images (X60) axons are represented in red (YFP) and myelin in 
green (myelin basic protein antibody). The upper two images are from a nerve repair specimen at 
twelve weeks post intervention. The lower two images from a nerve graft specimen at twelve 
weeks post intervention. In both cases all axons are surrounded by a myelin sheath. The red 
arrows illustrate empty myelin sheaths. 
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Figure 45. 
Two photon microscope images showing multiple axons in single myelin sheaths and empty 
sheaths. 
	
	
This is a single-channel, two-photon image of a nerve repair specimen at six weeks. Axons have 
a bright signal and connective tissue is faint. The black spaces are Büngner's bands. It is not 
possible to ascertain the presence of myelin in this image. The red arrow indicates an unoccupied 
sheath. The yellow arrows indicate multiple axons within a single sheath. The yellow circles 
highlight these sheaths in the lower image. 
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5.3 Summary 
After nerve repair and graft, axons re-innervate the end-plate arbor within the muscle. The 
number of neuromuscular junctions remained constant across both intervention groups and 
controls. The number of axons that regenerate in the intervention groups appeared to be greater 
than those present in the control group. However, these axons are a mixed population with some 
large fibres and many smaller fibres. In the repair group the number of axons falls over time. 
This process was not identified in the graft population. 
The literature supports the notion that regenerating axons undergo branching and subsequent 
remodeling over time. However, estimates of the number of new fibres per original axon vary 
widely (106,302-304).  The patterns of reinnervation and motor unit size influence the 
characteristics of the muscle. The proximal number of axons is a more accurate representation of 
the true number of regenerating axons but still includes a mixture of axons and sub-branches 
from divisions that have occurred more proximally. Two techniques were employed to unravel 
this issue. The first was to analyse more closely the characteristics of the regenerating axons. The 
second was to use a different transgenic, the YFP-H, which is sparsely labeled to better visualize 
the patterns in the regenerating axons (see chapter 7). 
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6. 
Characterisation of the changes in motor unit size by 
controlling for axon size in YFP-16 mice 
 
6.1 Introduciton 
The cross sections of the nerves show that the populations of axons between the intervention and 
control groups appear different. The controls exhibit an homogenous collection of axons that 
appear similar in size. The axons in the repair and graft groups are heterogeneous with a few 
large fibres and multiple smaller ones (Fig 46). One possible reason for this change is that each 
axon is giving off multiple branches. Each division could be symmetrical producing equal 
smaller neurites, or asymmetrical retaining some larger and some smaller branches. Studies of 
YFP-H specimens suggest that both scenarios are possible (Fig 47). 
 
In the same way that branching occurs between the proximal and distal ends of the terminal 
nerve to the muscle, it is likely that branching occurs between the site of surgical intervention 
and the start of the terminal nerve. This is supported by previous studies that show axons 
branching both before and after a site of injury (104,305-308). Tracing the sparse labeled YFP-H 
mice also showed this to be possible (Fig 48). It can be assumed that not all of the axons counted 
at the proximal site originate from different cell bodies; some are likely to be branches of 
individual axons. To get an accurate estimation of motor unit size it is crucial to know which of 
the axons entering the muscle are true individuals and which are branches.  
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Figure 46. 
Two photon microscope image of cross sections of the terminal nerve to interscutularis in a 
control, a nerve repair and a nerve graft mouse 
A	 	
B	 	
C		 	
The single channel images are digital cross sections of image stacks taken in a two-photon 
microscope (63X). They show distal nerves at the junction with the muscle: A = control, B = 
repair at twelve weeks, C = graft at twelve weeks. The populations of axons in the intervention 
groups are more heterogeneous than the controls with a wide variation in their calibre and cross 
sectional outline.	  
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Figure 47. 
Two photon miscroscope image showing an axonal branch point in a YFP-H mouse after nerve 
graft 
 
This shows an axonal branching point within a nerve. The images on the left show the 
irregularity of the axonal outline alternating between pinch points and bulges. It is easy to see 
how these could be mistaken for branch points without the benefit of 3 dimensional stacks of 
images. The images on the right show where serial cross sections have been taken to follow and 
analyse sub-branches of a single axon (red outline). The branches are not equal in calibre. 
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Figure 48. 
Two photon microscope montages of YFP-H mice after nerve repair and traced axons 
illustrating branching patterns 
	
	 		
These are single channel two photon images of YFP-H sparse labeled specimens. Each is an 
example of a neuroma (left) which has been traced with each axon represented with a separate 
colour (right). The interesting features are the lack of branching at the point of the neuroma 
itself, with several axons subsequently branching in the distal nerves. In the upper image the red 
axon and the magenta axon in the lower image distribute of branches of individual axons into 
separate terminal nerves. This is physical evidence for synkinesis, with a single axon innervating 
different muscles. 
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The diameters of the axon populations vary significantly between the control and intervention 
groups. Some of the axons in the intervention groups are similar to those of controls, but many 
are smaller. These may represent sub-branches, which is supported by the reduction in axon 
numbers with remodeling. Some resemble be sensory or sympathetic fibres (Fig 49), neither of 
which would contribute to motor reinnervation. The original nerve to interscutularis contains 
only motor fibres (263). These could be fibres from other branches of the posterior auricular 
nerve that have entered the terminal nerve to interscutularis inappropriately. 
 
The traditional method for estimating the number of regenerating axons is to biopsy the distal 
end of the nerve or nerve graft. The biopsy is then stained with thionin and acridine orange, 
sectioned and imaged. The number of myelinated and unmyelinated fibres are counted (309). 
However, there are limitations to this technique. It cannot distinguish branches from true 
individual axons. This can create confusion even over short distances. In the present method a 
stack of digital cross sections runs over several microns. The morphology of an axon includes 
outpouchings that run alongside the main fibre for multiple slices. In traditional cross sections 
these would appear to be separate axons (Fig 50). Scrolling through a stack and tracing the 
outline of an axon minimizes the chance of these sampling errors occurring. This improves the 
accuracy but it was not practicable to create a digital stack that encompassed all axons from 
proximal to the repair site to the level of the neuromuscular junction. Lu managed a precise 
wiring diagram for the interscutularis in a small number of uninjured muscles, but only over a 
distance of approximately 5mm of the terminal nerve (252). It would not be feasible with current 
tracing algorithms to follow axons across the distance from the site of intervention to every 
junction in the muscle in a sufficient number of specimens to generate statistical power to 
comment on the difference between repairs and grafts. 
	 133	
Figure 49. 
Confocal microscope image the end plate zone in a nerve cut mouse showing aberrant reinnervation 
	
	 	
In this nerve cut specimen the neural arbor has been reoccupied by YFP axons. The axons have 
not re-established connections, or made de novo neuromuscular junctions, with the muscle, 
despite the presence of unoccupied junctions on the muscle surface. These YFP axons are still 
labeled with fluorophore, but have a very different morphology from the motor axons normally 
encountered innervating the interscutularis. They are of smaller calibre and have a characteristic 
wavy course that resembles sympathetic axons (personal communication with JW Lichtman). 
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Figure 50a. 
Stack of two photon images showing details of axonal morphology at a node and possible branch point 
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Figure 50b. 
Stack of two photon images showing cross sections of the images from Fig 52a  
	
	
		
These are two-photon images of regenerating axons in a YFP-16 mouse six weeks after a nerve 
graft. The sequential series of images in figure 50a are part of a stack. In the first image of the 
sequence there are two axons in boxes. The red box shows the outline of an axon at the site of a 
node of Ranvier. This demonstrates the potential variation in axon calibre if sampled through a 
node. The axon in the green box has been digitally cross-sectioned in the direction of the arrow. 
Those cross sections are the sequence in figure 50b. In subsequent images from the stack the 
irregularities of the outline of this axon are demonstrated by the red arrow and a branching point 
1
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by the green arrow. The sub-branch doubles back on itself (second green arrow). Figure 50b is 
the sequential series of digital cross sections. In the green box (section 1) the irregular outline 
indicated by the red arrow in figure 50a can be seen in cross section. These complex longitudinal 
bulges can easily be mistaken for branching points if a section were taken in isolation. Scrolling 
though the 3-dimensional stack enabled these sampling errors to be excluded. The green arrow 
indicates the point where the axon does branch. The red circle indicates where the sub-branch 
has doubled back and is travelling in the opposite direction. The point at which it doubles-back is 
in the last image. 
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The disparity between the control and intervention groups suggest that axon diameter could be 
used as a tool to estimate true axon numbers more accurately. A model motor axon population 
was calculated from two standard deviations of the mean diameter of the proximal axons in 
controls. This produced a minimum threshold axon diameter of 5.5µm. All axons with smaller 
diameters were excluded and the axon populations re-examined (Fig 51).  
 
6.2 Results 
 
The mean number of distal axons per specimen in the control group is 23.1 ± 5.8 (n=16). 
Thresholding reduced this to 20 ± 5.1 (n=16). The difference between the number of proximal 
axons and the number of thresholded distal axons was 2% (p=0.8, paired t-test, Fig 52). In the 
non-thresholded group there was an increase of 19.7% over the length of the terminal nerve. This 
supports the notion that sub-branches were excluded from the data and only true individual axons 
were retained. 
 
In both intervention groups the number of proximal axons included within the threshold 
increased over time (Table 16). The repair group was stable at approximately 11 axons at weeks 
four and six but rose to 15 axons by week twelve. Conversely the graft group initially rose from 
7 axons to 10 axons between weeks four and six but then remained stable between six and twelve 
weeks. These trends do not match those seen in the non-thresholded axon numbers (Fig 53). In 
the non-thresholded data the number of proximal axons falls in the repair group over time from 
34.7 axons at four weeks to 27.6 axons at twelve weeks. In the graft group it remained stable at 
approximately 29 axons throughout (see Chapter 5).   
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Figure 51. 
Cross section of a two photon stack of the terminal nerve illustrating thresholding of axons 
according to their calibre. 
	
		
This is a digital cross section taken from a two-photon stack of images of a nerve in a YFP-16 
mouse 6 weeks after nerve graft. The axons that are within two standard deviations have been 
highlighted in red.  
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Table 16. 
Mean axon numbers after thresholding to exclude axons with a diameter less than 5.5µm. Mean 
± Standard deviation (n) 
  Weeks Proximal Axon Number 
Mean    (S.D., n) 
Distal Axon Number 
Mean    (S.D., n) 
Controls  19.6 ± 4.6 (16) 23.1 ± 5.8 (16) 
Repair 4 11.9 ± 2.3 (7) 13.1 ± 6.8 (7) 
6 10.8 ± 1.3 (8) 16.6 ± 4.1 (8) 
12 15.4 ± 5.2 (8) 16.0 ± 5.6 (8) 
Graft 4 7.1 ± 3.3 (9) 9.9 ± 3.9 (9) 
6 10.0 ± 4.0 (9) 12.9 ± 6.6 (9) 
12 11.1 ± 3.3 (9) 16.4 ± 6.0 (9) 
 
The number of thresholded distal axons increased over time in both intervention groups, though 
the trend is the reverse of what was identified proximally. The repair group initially increased 
and then plateaued from six weeks. The graft group steadily increased throughout the time 
points. Both groups (repair and graft) converge at approximately 16 axons distally. 
 
Comparing the change in number of axons proximal-to-distal in both groups over time between 
the thresholded and non-thresholded data it was apparent that these trends remained the same. In 
the repair group there was evidence of a remodeling process occurring. Over time the amount of 
branching levels off. This trend was not observed in the graft group and numbers steadily 
increased over time.  
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Figure 52 illustrates how thresholding axons in control specimens according to their diameters (2 s.d. of mean) removes the branches 
seen in the terminal nerve to interscutularis. There is no significant difference in axon numbers between the proximal and distal sampling 
points. In figure 53 thresholding at the proximal sampling point in the intervention groups reduces the number of axons to fewer than 
the controls at all time points. The trend over time is also reversed with both intervention groups now increasing the number of axons 
over time. Neither repairs of grafts achieve the same proportions as controls.
Figure 52 Figure 53
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The mean axon diameters of each intervention, at each time period, were significantly smaller 
than controls (see Chapter 5). Once the diameters had been thresholded, the mean axon diameters 
of the intervention groups resembled the control population more closely (Table 17). However, 
they were still skewed towards smaller axons, and had fewer larger axons greater than 10µm in 
diameter than the controls populations (Fig 54). 
 
Despite thresholding, the mean axon diameters of the intervention groups at the proximal 
sampling point were still not identical to controls. Whilst there was no statistical significance 
comparing intervention and time (p=0.703), the difference between the intervention groups was 
found to be significant (p=0.008). The mean axon diameters of the control group were 
significantly larger than the thresholded graft group (p=0.007), but the difference between the 
thresholded repair group and either the thresholded grafts, or the controls was not significant.  
 
At the distally sampling point there was no significant difference in the diameter of the axons 
between either thresholded intervention and control groups (p=0.371) or between repair and graft  
(p=0.714) or at any time point (p=0.435).
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Figure 54 
 
After thresholding the histograms of axon diameters for both intervention groups at the proximal sampling point resemble the control axon 
population much more closely. Two way ANOVA is not significant however, multi variant analysis shows the grafted axons to be significantly 
smaller than the controls (p=0.007). In both interventions the axon diameters are still skewed to the left and there are fewer axons greater than 
10µm than in controls. 
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Table 17. 
Axon Diameters (proximally and distally) in thresholded repairs and grafts compared to controls. 
Mean ± Standard deviation (n) 
  Weeks Proximal Diameter µm 
Mean    (S.D., n) 
Distal Diameter µm 
Mean    (S.D., n) 
Control  8.0 ± 1.2 (313) 7.7 ± 1.2 (393) 
Repair 4 7.7 ± 1.3 (83) 7.3 ± 1.1 (137) 
6 7.7 ± 1.2 (87) 7.7 ± 1.2 (142) 
12 8.5 ± 1.4 (123) 9.0 ± 2.4 (167) 
Graft 4 7.4 ± 1.4 (64) 7.0 ± 1.0 (89) 
6 7.7 ± 1.3 (90) 9.8 ± 3.1 (117) 
12 7.8 ± 1.5 (100) 7.7 ± 1.4 (148) 
 
 
The motor unit size in the control group was 14.0 ± 2.5 junctions/axon (n=16). If thresholding 
data does give a more accurate count of the axons regenerating after repair or graft, by removing 
branches then it suggests that fewer axons re-occupy the neuromuscular arbor. This would 
increase the size of the motor units. Recalculating the motor unit sizes using these thresholded 
axon populations in each of the intervention groups both proximally and distally the mean motor 
unit size for repairs was 24.9 ± 10.76 junctions/axon (n=24) proximally and 20.0 ± 8.4 
junctions/axon (n=27) distally. The graft group were 35.6 ± 24.3 junctions/axon (n=27) 
proximally and 26.2 ± 17.6 junctions/axon (n=27) distally. These motor units were larger (each 
axon innervates more junctions) than the control group. This contrasts with the non-thresholded 
data where they were smaller. They were also reducing in size over time for both repairs and 
grafts(Table 18, Fig 55). Since the number of neuromuscular junctions remained stable (vide 
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supra) this indicates an increase in the number of axons included in the thresholding. This could 
indicate the growth in the size of true axons as sub-branches are trimmed due to remodeling. 
 
Two way ANOVA of intervention and time illustrated that there was not a significant difference 
in the size of the motor units between the control and thresholded intervention groups (p=0.068). 
However, the difference between the groups was significant (p=0.012). The difference between 
the four and twelve week data sets also showing significance (p=0.016) as the axon populations 
are remodeled. 
 
Table 18. 
Motor unit size after axon diameter thresholding to exclude axons with a diameter less than 
5.5µm. Mean ± Sandard deviation (n) 
  Weeks Proximal Motor Unit Size 
Mean    (S.D., n) 
Distal Motor Unit Size 
Mean    (S.D., n) 
Controls 14.0 ± 2.5 (16)  
Repair 4 23.0 ± 7.3 (7) 22.0 ± 9.4 (7) 
6 28.7 ± 3.5 (8) 21.0 ± 7.5 (8) 
12 18.0 ± 5.7 (8) 16.9 ± 8.2 (8) 
Graft 4 51.5 ± 33.6 (9) 32.5 ± 14.9 (9) 
6 32.5 ± 17.5 (9) 30.1 ± 24.3 (9) 
12 22.7 ± 3.2 (9) 16.0 ± 4.0 (9) 
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Figure 55.
 
 
This figure illustrates how the mean motor unit sizes in both intervention groups are much larger 
than controls when the axon numbers have been thresholded according to diameter. In addition 
the trend for the mean motor unit size to fall over time in both intervention groups. Previously 
this was seen only in the grafted group. 
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6.3 Summary 
The smallest axonal fibres with diameters less than 2 standard deviations of the control 
population of motor axons are unlikely to contribute to motor reinnervation. If they are included 
in the calculation of motor unit size the motor units appear to be small. This would suggest that 
there are fewer muscle fibres per axon which would confer increased fine motor control. Over 
time the size of the motor units in this non-thresholded data increased as axons are remodeled 
and pruned. If these small axons are excluded the motor unit sizes of the intervention groups are 
larger than controls. This would imply that there are fewer individual axons regenerating to 
occupy the same number of junctions and muscle fibres which is consistent with approximately 
40% of axons regenerating across a repair site (310). The number of thresholded axons at the 
proximal point increases over time in both interventional groups. This would be consistent with a 
gradual increase in diameter of some small axons (that are initially filtered out) as they take over 
the territories of less successful smaller sub-branches and get more of a foothold in the 
reinnervated muscle (298,311-315). 
  
	 147	
7. 
Grapes, sprouts, bundles and branches: A qualitative 
characterisation of the intra- and extra-muscular changes 
seen after reinnervation in YFP-H and YFP-16 mice 
 
7.1 Introduction 
 
In the preceding chapters we have set out a quantitative evaluation of the patterns of 
reinnervation after nerve repair or nerve graft. An advantage of transgenic animals that express 
fluorescent proteins in their peripheral axons is that it makes it possible to image the entire arbor 
of that regenerating nerve. The regenerated axons are displayed almost as a time-lapse of the 
process of reinnervation. In addition to the statistical analysis it is useful to review the overall 
patterns of the reinnervation, more specifically focusing on the changes in the morphology of the 
axons and junctions that are not adequately communicated in a quantitative manner. 
 
YFP is sparsely expressed in the YFP-H line with only 5-10% of axons labeled with the protein. 
This allowed us to view single axons without the distraction of the entire population. In a similar 
way to Cajal’s silver staining, this allowed analysis of the patterns of regeneration taken by 
individual axons in the reinnervation of the muscle. Observing axons at twelve weeks, after 
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remodeling has occurred, shows the branching patterns of successful axons that have made 
connections with NMJ in the muscle. 
 
7.2 Results 
 
There are several interesting results from this group. Some axons undergo multiple divisions at 
several distinct branching points to produce a myriad of sub-branches. Other axons have no 
branches at all. Some axons have sub-branches that enter different terminal nerves that supply 
different end-organ muscle targets. This is direct evidence of synkinesis.  Some axons perform 
several loops at the site of the neuroma before entering the distal nerve, whilst others travel 
across the site of repair directly unhindered (Fig 48) 
 
The data above has shown that there is no change in the number of junctions, but that the 
reinnervated junctions, in both repair and graft, are smaller than the control group. The junctions 
gradually increase in size over time but do not recover their original cross sectional areas, as 
demonstrated by the control junction population. In addition, there are changes in the junctional 
morphology that are harder to quantify. Many junctions lose their distinctive “pretzel-like” 
quality and the end-plate gutter becomes thinner and more fragmented. In a few cases the 
junction resembles a bunch of grapes with small beaded areas of double-labeled end plate 
receptors that are strung out and discontinuous. It is not possible to tell if these more disrupted 
junctions are single junctions that have disintegrated or areas of new junction forming de novo 
on denervated muscle fibres. There is a spectrum of junctional morphology in reinnervated 
muscles that ranges from normal through to strings of tiny bead-like receptor zones (Figs 56 and 
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57). These changes are present at junctions in all reinnervated muscles and whilst they are more 
prevalent in the specimens at four weeks they appear to persist over time. There is evidence of 
grapes and beads in muscles at twelve weeks following both nerve repair and nerve graft. Several 
of the graft muscles at four and six weeks have what appear to be much smaller junctions than 
normal. Reviewing the mean surface area for these specimens shows that they have the smallest 
mean junction sizes in their time groups.  These junctions resemble those seen in the nerve cut 
group at four weeks, but are double-labeled showing that the end-plates have been re-occupied 
by regenerating axons. This might indicate a delay in the process of axon regeneration.  
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Figure 56. 
Confocal microscope images of morphological changes at NMJ four weeks after a nerve repair 
  
	
	
	These	 double-labeled	 images	 are	 of	 a	 nerve	 repair	 specimen	 four	 weeks	 after	 intervention.	 The	receptor	gutters	of	the	junctions	have	lost	some	of	their	continuity,	loosing	the	‘pretzel’	shape	of	the	control	junctions.	The	green	axons	are	disordered	and	more	loosely	fasciculated	than	normal,	and	some	have	put	out	some	terminal	sprouts	from	occupied	junctions.	 	
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In conjunction with the changes noted in the end-plates there is also a change in the 
intramuscular axons. The most immediately obvious change being a looseness to the main axon 
bundles, the trunk and main boughs, to follow the arbor analogy. In the control specimens these 
are closely fasciculated with axons tightly packed together. In the reinnervated muscles these 
main bundles are less constrained and the individual axons are more loosely bound together. 
Again this appears to persist over time. At the junctions the axons exhibit several features not 
seen in the control group. As mentioned above the extent of reinnervation as measured by re-
occupation of junctions could be considered complete. The number of double-labeled junctions 
was no different in interventions or controls. There were only four muscles that showed any 
completely denervated junctions, two nerve repair specimens, one at four and one at six weeks, 
and two nerve graft specimens, again at four and six weeks. In each case it was a small number 
of junctions (R4=3/343; R6=30/308; G4=5/330; G6=4/318) and the junctions were of normal 
architecture (Fig 57). Partial innervation, where the junction was only partially covered by an 
axon, was also a rare occurrence (Fig 57). Two repairs at six weeks had 4 (of 319) and 5 (of 308) 
partially innervated junctions respectively, and one graft at four weeks had 7 (of 318) partially 
innervated junctions. In two muscles, a repair and a graft each at twelve weeks appeared to show 
a single junction that was poly-innervated by two separate axons (Fig 58). Four grafted muscles 
at 6 weeks showed junctions innervated in series where an axon occupied one junction and then 
continued via a terminal sprout to occupy another junction (Fig 59). Whilst the number of 
junctions innervated in this way was low the presence of terminal axonal sprouts was much more 
prevalent. All reinnervated muscles at all time frames showed some evidence of terminal 
sprouting. The degree of terminal sprouting was subjectively greatest at earlier time frames and 
in the grafted muscles. In both repairs and grafts it reduced with time but did not totally resolve. 
The terminal sprouts were not uniform in character. They varied from thin spidery tendrils  
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Figure 57. Confocal microscope image of denervated NMJ in a reinnervated muscle. 
 
	
	 	
In this nerve repair specimen at six weeks there is an example of both a partially reinnervated neuromuscular junction, and two junctions 
that has not been reinnervated. The upper image is double labeled with axons in green and junctions in red. The lower left image shows 
only the green channel (axons). One branch overlies three junctions, innervated in series. The gutter of the first junction is only partially 
occupied. The second and third junctions have atrophied, but the remaining gutter is completely occupied. The lower right image shows 
the red channel (NMJ) which demonstrates five junctions. Two of these have not been reinnervated at all. 
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Figure 58. 
Confocal microscope image of polyinnevated NMJ in a reinnervated muscle 
 
	
	 	
This double-labeled image is a nerve repair specimen four weeks after intervention. The green 
arrow indicates a neuromuscular junction that receives polyinnervation from two axons. One of 
these is itself a terminal branch from an adjacent junction.  
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Figure 59. 
Confocal microscope image of terminal sprouting 
 
	
This double-labeled image is from a nerve graft specimen, six weeks after intervention. An axon 
(green arrow) innervates three neuromuscular junctions (red arrows) in series. Having occupied 
the first junction, a terminal branch proceeds to two further junctions. In addition a further 
terminal branch (blue arrow) is visible extending from a separate junction. 
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Figure 60. Confocal microscope image showing sprouts, webs and tendrils in reinnervated muscle 
 
 
 
This double-labeled image of a nerve graft specimen at six weeks post intervention shows a number of changes in both axons and 
neuromuscular junctions. The junctions (red arrows) have loss of gutter continuity, resembling ‘bunches of grapes’ rather than the normal 
‘pretzel’. The axons show numerous terminal sprouts and terminal branches (green arrows).  
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spreading out with minimal alteration in vector, to confused webs of matted fibres with blebs and 
condensations (Fig 60). Where these terminal sprouts were most prevalent they were often 
associated with bunches of grape-like junctional end-plates. Occasionally an axon appears to 
enter the arbor and not make any connections with junctions (Fig 49). These axons have a 
characteristic wavy appearance that resembles sympathetic fibres (personal communication with 
JW Lichtman). 
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8.  
Discussion  
 
8.1 Overview of Reinnervation 
 
The overwhelming impression when looking at the muscles in this study is that there has been a 
remarkable degree of reinnervation. This is the case with both nerve repair and nerve graft at 
each of the three time periods studied. The neural arbor is reoccupied and the neuromuscular 
junctions are present with the normal "pretzel" appearance seen in control animals. This in itself 
is a testament to the reinnervation process. The purpose of this study was to examine the changes 
in both the muscle and the nerve after reinnervation. The aim was to correlate these changes with 
possible causes of reduced function in the clinical scenario of free-functional muscle transfer for 
facial reanimation. To reconstruct facial palsy a muscle is transferred to the face and 
reinnervated by a branch of a cranial nerve, either via a direct repair or through a nerve graft. In 
this study we focused on a branch of the facial nerve and assessed the differences in 
reinnervation between two possible interventions: nerve repair (R) and nerve graft (G). There are 
twenty seven animals per intervention divided equally between three time periods: four, six and 
twelve weeks. By observing the changes that occur over time, as the returning axons reoccupy 
the distal nerve stump and neuromuscular junctions, we hope to assess how the relationship 
between the nerve and muscle matures. By comparing the results twelve weeks after surgical 
intervention we hope to assess longer-term differences between the two interventions and the 
control group. The choice of twelve weeks is a compromise, to balance the differences seen from 
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maturation of reinnervation and remodeling of the arbor, with the degenerative changes 
associated with ageing (316,317). 
 
Initial pilot studies in YFP mice suggested that a regenerating nerve that has been damaged in the 
lateral neck arrives at the denervated muscle two to four days after a nerve crush, and 
approximately two weeks after a nerve repair or graft. Several parameters were measured to 
assess the regenerating nerve and the reinnervated muscle. To assess the nerve the number and 
calibre of the axons were measured at two locations within the nerve: at the start of the terminal 
nerve branch to the muscle (i.e. where the only target organ remaining is the interscutularis 
muscle) and just before the nerve enters the muscle (i.e. its most distal extra-muscular point). 
Immunohistochemical labeling was used to identify the presence of a myelin sheath around the 
axons. The muscle was imaged to identify the neuromuscular junctions that were double-labeled 
for bungarotoxin (acetylcholine receptors) and axons (YFP), indicating that they had been 
reinnervated. The number and area of those neuromuscular junctions was measured. 
 
The total number of neuromuscular junctions remains stable in both the nerve repair and nerve 
graft groups with respect to controls at each of the time periods. This suggests that the number of 
muscle fibres is also stable, since only one mature junction forms per fibre. Images from the 
nerve cut controls show that the disintegration of the end-plates is a gradual process. Almost all 
of the junctions retain a normal contour four weeks after denervation. Over time the number of 
normal junctions declines. By six weeks there are still junctions that are recognisable as end 
plates despite being small, although most junctions have totally degenerated and disappeared. By 
twelve weeks there are scattered fragments that label with alpha-bungarotoxin, but no 
recognizable junctions (Fig 34). It was initially surprising to see any junctions with normal 
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architecture six weeks after denervation. However, this finding supports the idea that rapid 
junction turnover occurs during reinnervation and is related to asynchronous innervation (318-
320). In the total absence of synaptic activity there is a gradual shrinking of the junction with 
atrophy of the muscle fibre, but no impetus for rapid resorption (287,321).  
 
At four weeks after nerve repair or nerve graft most of the junctions have a normal morphology 
but are smaller than normal NMJ. The reduction in the size of the junctions probably reflects 
some muscle fibre atrophy that occurred during the period of denervation that is not yet restored 
(322). The junctions in the nerve cut controls demonstrate the gradual shrinkage seen with 
denervation. Comparing the size of the junctions from the two intervention groups with those of 
the nerve cut controls, we see that the repair group is larger by four weeks, whilst the graft group 
is slightly smaller. This is biased by the reduction in numbers of junctions that are still 
measureable in the nerve cut controls, which may represent junctions that were larger than the 
mean prior to denervation. It does suggest that there has been some return to function and a 
reversal of muscle fibre atrophy resulting in a recovery of junction size in the repair group by 
four weeks. Over time the junctions in both intervention groups continue to increase in size but 
plateau between six and twelve weeks. The repair group recovered 94% of the mean size of 
control junctions by twelve weeks, whilst the graft group achieved 77%. However the total 
surface area of reoccupied junctions was less, with repairs reaching 77% and grafts 61% of 
controls. The junctions recovered more than the 20% safety factor required for function (323). 
Given that the number of junctions did not change, this indicates that each muscle fibre, and 
hence junction, increased in size as it regained function over time, but that the recovery of the 
muscle was globally reduced. This might be as a result of chronic changes in the muscle fibres 
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after a period of total denervation, or perhaps reflects a reduced capacity of the returning axons 
to restore the full complement of junctions to their original state. 
 
There are morphological changes exhibited by some of the junctions. There are several examples 
of junctions where the receptor gutters loose continuity and appear thinner and more fragmented 
(Figs 58-62). The receptor areas are only partially occupied or inaccurately covered by the nerve. 
Where this occurs it is often accompanied by changes in the appearance of the axons in the peri-
junctional area. Some axons are very thin and show peri-terminal blebbing, and occasionally 
there will be polyinnervation of a single site by several different axons (Figs 57 & 59). These are 
all features akin to the signs of ageing at the neuromuscular junction identified by Valdez (Fig 
61) (5). The degree of poly-innervation however, was rare and observed in only two junctions 
across two muscles. This is in agreement with the long term outcomes described by Luff (223). 
These changes are seen in specimens at all time periods in both intervention groups, and do not 
resolve with remodeling of the arbor. Comparison of the junctions from a nerve repair or nerve 
graft specimen with those of its contralateral control muscle show that these junctions remain 
altered when directly controlled for age. It would be interesting to ascertain if these changes were 
initiated by the axons, or by the junctions.  It is possible that these altered junctions are 
associated with a particular population of axons, perhaps those with very enlarged motor units 
that are over-stretched. There is no impression from the YFP-16 specimens that all the “aged” 
junctions are associated with a particular axon (i.e. a single motor unit) and they are too 
numerous to attribute to identified axons. This change in morphology may have an impact on the 
muscle characteristics after reinnervation in a similar way to age related deterioration, with 
reduced coordination and power of contraction. This would have consequences for all free-
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functional muscle transfers, be they for facial reanimation or brachial plexus reconstruction. 
Muscles with aged junctions have been shown to contract less effectively than controls (324). 
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Figure 61. 
Valdez’s images of age related change in NMJ (2010) 
 	
Age-related changes in the neuromuscular system. (A) Tibialis anterior muscle  in a young adult mouse 
that expressed YFP in motor axons. In the region shown, two  nerve bundles (yellow)  innervated 
individual muscle  fibers. AChRs were labeled with Alexa-594-BTX (red). Complete apposition 
between nerve terminals and AChRs is typical in young animals. (B) Tibialis anterior muscle in a 24-mo-
old mouse. Denervated (arrows) and partially vacated AChR sites as well as prominent axonal swellings 
(arrowheads) are common. Young adult (C ) and aged (D–J) NMJs are shown at higher magnification. 
Age-related alterations included complete denervation of the postsynaptic AChR site (D), 
fragmentation and faintly labeled patches of receptors (E ), and receptors that are only partially 
covered by the nerve terminal (E–F ). In some  cases the innervating axons  are very thin (G), bear large 
swellings proximal to the nerve terminal (H), multiply innervate one NMJ (I), or extend processes 
beyond the receptor area (J). [Scale bars:  50 µm (A–B) and 10 µm (C–J.) 
Images of age related changes in axons and neuromuscular junctions from Valdez et al in PNAS 
2010 (5). Many of these morphological changes are reminiscent of the changes we have 
observed after reinnervation. 	
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The nerve cut group demonstrated some interesting changes in this regard. As previously 
mentioned the surgical protocol in the nerve cut group was revised once initial results showed 
that, despite excision of a 1cm segment of nerve, some specimens were showing reoccupation of 
the arbor. Examination of the site of the excision revealed a large, uncoordinated neuroma in 
continuity. The axons form a loose helical structure as they cross the unsupported area between 
the nerve ends (Fig 7). To prevent this the parotid gland was mobilized and interposed between 
the cut ends of the nerve as a barrier. However, there were a number of specimens from the 
original protocol examined at four, six and twelve weeks, that demonstrated unusual features that 
are worth discussion. In one muscle at four weeks, one at six weeks, and two at twelve weeks, 
the familiar arbor has been reoccupied by YFP axons, but the nerves do not make any 
connections with the neuromuscular junctions. The axons have a different appearance from the 
normal motor axons, they are thin and often blebbed and perhaps represent sensory or 
sympathetic fibres (Fig 49). In one specimen, six weeks after nerve cut, the junctions have been 
reoccupied but the neuromuscular junctions exhibit an extreme version of the changes noted 
above in some of the nerve repair and nerve graft specimens. The end-plates are ill-defined and 
fragmented (Fig 62). There is excessive terminal sprouting with numerous junctions innervated 
in series as opposed to parallel. These changes are presumably due to a longer delay in 
reinnervation caused by the time it took the axons to cross the gap between the cut ends 
unsupported by bands of Büngner. It is interesting that in the repair and graft group the changes, 
whilst more subtle, are seen in specimens at four, six and twelve weeks. This suggests that these 
changes in junctional morphology are not restored with time, and that any degradation of the 
junction associated with a delay in reinnervation may be a permanent feature. 
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Figure 62. Confocal microscope montage of NMJ in late reinnervation (nerve cut) 
 
 
	
This specimen six weeks after a nerve cut (original protocol) shows changes in the 
neuromuscular junctions. They are double-labeled and thus reinnervated, however the junctions 
are small and fragmented. This may reflect the delay in reinnervation as the axons traversed the 
un-repaired nerve division. 
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One strategy to increase the ultimate power of contraction of the transferred muscle in facial 
reanimation has been to transfer a larger-than-required muscle to allow for the atrophy that 
occurs in the lag time before reinnervation, whilst the nerve regenerates. Animal studies have 
shown that a transfered muscle will atrophy by as much as 50% before it is reinnervated, but 
retain sufficient numbers of fibres to provide adequate power and excursion once functional 
(325-327). Fu demonstrated that where muscles were reinnervated after a six month period of 
chronic denervation, they regenerated approximately 50% of functional muscle fibres (226). 
Human nerves regenerate at approximately 1mm per day. A six month period of denervation 
therefore correlates with a growth distance of 150-180mm, approximately the distance a cross-
facial nerve graft has to span in a classical two-stage facial reanimation procedure. Performing 
facial reanimation in two stages enables axons to be present at the distal end of the graft, 
reducing the distance the axons subsequently have to regenerate at the time of muscle transfer. 
This minimizes the period of time the muscle is denervated and thus the extent of its atrophy. 
However, this strategy does mean that the axons of the cross-facial nerve graft are deprived of a 
distal target for a significant period of time, whilst they are growing across the face. 
 
Henneman proposed the size principle for the activation of motor units, which is key to the 
coordinated function of a muscle (111). Smaller units, where an axon innervates only a few 
muscle fibres, contract first and larger units are activated as more force is required. The number 
and ratio of small and large motor units within any muscle are related to the tasks it performs. A 
disruption in this balance would alter the normal sequence of recruitment and affect a muscle’s 
ability to perform those tasks. In reinnervation the number of axons that regenerate and the 
number of junctions that are successfully reoccupied, determines the size of the recovered motor 
units. We believe that disruption of these motor unit proportions is key to the variability in the 
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success of free-functional muscle transfers. Urso-Baiarda postulated the bottle neck theory of 
reinnervation, suggesting that there are two potential culprits that can disrupt the motor unit 
ratios and lead to poor function (328). If there are insufficient available muscle fibres due to 
atrophy the muscle becomes the bottleneck. In this case harmony can be restored by remodeling 
of the regenerated axons. If there are insufficient regenerating axons the nerve becomes the 
bottleneck. The regenerating axons are overstretched in their attempt to innervate the available 
muscle fibres. Remodeling of axons cannot restore the size principle and contractions will be 
disorganized (Fig 63). 
 
Jacobs and MacQuillan have suggested that the number of axons regenerating to the distal end of 
the nerve graft is equal to or surpasses that of the normal nerve (81,288). This would suggest that 
the cause of the bottleneck is therefore the muscle, and support the theory that transferring a 
larger muscle could improve results. However, Mussini and Schmalbruch have shown that 
muscle atrophy after denervation is not, in itself, the only cause of poor reinnervation, and that 
muscle fibres that have been denervated for several months can still regenerate once a stimulus is 
restored (217,218). In addition axons that have been chronically deprived of a target have a 
reduced ability to effectively re-innervate a muscle (219,329,330). Similarly Scwhann cells 
become less able to nourish axons after long periods without their trophic support (226,330). 
This suggests that the focus on reducing the period of denervation of the muscle may be 
misguided. It might be that the ratio between the number of muscle fibres and the number of 
axons, at the moment when the nerve reoccupies the neuromuscular arbor, is vital to its 
reinnervation characteristics. 
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Figure 63. 
Cartoon of the Bottleneck theory of reinnervation 
 
Remodeling of motor units according to the bottleneck theory. Restoration of the motor unit 
proportions is dependent of the number of regenerating axons. 
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Unlike Jacobs and MacQuillan, Frey and Terzis have reported a reduced number of axons at the 
distal extent of the cross-facial nerve graft (83,84). If the nerve is the bottleneck then a large 
number of muscle fibres might exceed the capacity of the regenerating axons to increase the size 
of their motor units. Perhaps we should turn our attention to the quality of the regenerating 
axons. Terzis has shown a correlation between a greater number of axons in a donor nerve, and 
improved functional and aesthetic outcome in facial reanimation (84). We have shown that the 
number of neuromuscular junctions remains the same after nerve repair or graft. If the number of 
junctions remains the same, the size and nature of the motor units becomes dependent on the 
number of axons that re-innervate the muscle. If the number of axons also remains the same, the 
mean motor unit size should stay constant. If it changes it will affect the number of muscle fibres 
each axon controls. Axons have been shown to be able to increase their sphere of influence 4-6 
fold (221,222). However motor units greater than 6 times normal size are not stable and those 
axons are no longer capable of sustaining tetanic force (222-225,324). This suggests that there is 
an upper limit of the amount of work each axon can sustain. In addition, the amount axons are 
able to expand their influence is also reduced in older axons (331-333). 
 
Larger axons have larger motor units. Lu has shown that there is a direct relationship between 
the calibre of an axon and its motor unit size, with the increase in cross sectional area scaled to 
the square of the motor unit size (252). It is not clear whether an axon that enlarges the size of its 
motor unit can match the output of an axon that would normally innervate that many muscle 
fibres. After a nerve crush there is accurate reoccupation of the normal arbor and restoration of 
original motor units (103). However after more significant nerve injury this pattern is disrupted. 
Nguyen has shown that the proportion of junctions reinnervated by their original axons falls from 
over 95% with a nerve crush to less than 5% after a nerve division. In a nerve repair the picture 
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is more akin to the nerve division group, in that there is a discontinuity between the proximal and 
distal nerve stumps and complete disruption of the glial architecture. The physical approximation 
of the cut ends cannot restore the undamaged state. It serves to reduce the size of the gap 
between the ends and to make the loss of axons into the surrounding tissues less likely. Even if 
100% of axons entered the distal stump, there is little chance that they would re-enter their 
original tubes and therefore their original arbors. In a nerve graft axons have to cross two repair 
sites, which further reduces axon numbers in the distal stump, and the chances of an accurate re-
wiring of the circuit. In these scenarios disruption of the normal motor unit sizes and ratios 
seems inevitable. In free functional muscle transfer these patterns are further complicated by the 
pairing of a nerve and muscle that would not normally interact. The returning nerve has to 
navigate a foreign arbor.  
In the YFP animals we can trace the nerve from the point where it enters the muscle, back 
towards the site of nerve repair or nerve graft. The axons look well ordered within the terminal 
branch but there is variability in axon diameter that is not seen in the normal controls. At the site 
of neurorraphy there is a considerable change in the nerve. The ordered axons appear to break 
free and tumble over one another. This is a neuroma, and in the YFP-16 animals there is a 
disordered whorl of axons that seem to form numerous tight loops (Fig 12). Even here though, it 
is astonishing to see how quickly order is restored once the axons enter the distal stump. Within 
the space of a few microns they recover the gross appearance of the normal nerve. In the case of 
the graft there is a second neuroma, much the same as the first. Here again it is remarkable how 
much order there is in the substance of the graft, with axons tightly restrained for the section of 
transferred nerve between the two neuromas (Fig 35). It is an anatomical necessity of this 
methodology that the graft is quite short, and it is possible to see a few axons that have found the 
distal stumps despite bypassing the graft. These results suggest that once axons escape the 
proximal stump they undertake a searching pattern to seek the distal stump. This process is 
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provoked by neurotropic mediators and is powerful enough to entice axons over considerable 
distances. This is especially apparent in some of the pilot specimens in the nerve cut control 
groups. Here the neuroma continues to grow, forming a helical structure until the axons find the 
distal stump over 10 mm away. Once the distal Schwann cell tubes were occupied order was 
again restored and the muscle arbor reoccupied (Fig 7). This necessitated a change in the surgical 
protocol for the nerve cut group. Rather than a simple excision of a segment of nerve, the parotid 
gland was interposed as a barrier between the cut ends to prevent reinnervation by the original 
nerve. 
 
In two early nerve cut specimens, prior to the change in protocol mentioned above, the arbor 
appears to be restored but the junctions are not reoccupied (i.e. not double-labeled with YFP and 
alpha bungarotoxin) and resemble those of the other nerve cut samples (Fig 49). The axons are 
small and wavy with numerous small branching points. These axons could be sensory or 
autonomic in nature. Once the Büngner’s bands have been occupied it may be physically 
difficult for more axons to enter and displace those already there. It is unresolved whether the 
capacity of the Schwann cell tube can limit the eventual size of the regenerating axons. If the 
arbor is reoccupied by inappropriate sensory axons, it may reduce or prevent the ability of the 
returning motor axons to displace them and therefore result in a weakened or functionless 
muscle. 
 
The YFP-H animals, where there is fluorescent expression in only a small percentage of the 
axons, provide a tool for examining the patterns of axonal regeneration at the site of the repair, 
and the distal nerve, in more detail. The neuroma in the YFP-16 specimens appears to be a 
maelstrom of axons with each axon, and possibly multiple branches, making several turns and 
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contributing to the chaos. It is clear from the YFP-H specimens that each axon makes a small 
contribution to the overall picture. Some pass directly through the repair with almost no 
deviation. Others make one, or two rotations of 360 degrees before passing into the distal stump. 
Some axons appear to form multiple loops and never enter the distal nerve. Some of the three 
dimensional information is lost as the neuroma is squashed in the Z plane during imaging. It is 
possible that these axons have left the site of repair and are lost to the surrounding connective 
tissue. Branching within the repair site is rare and tends to occur once the axons are within the 
distal Schwann cell tubes (Fig 50). Intuitively it would seem advantageous to divide early and 
often, producing multiple ‘daughter’ branches each with an opportunity to find the distal stump. 
It may be the case in our specimens that the unsuccessful branches have already been retracted 
and remodeled. However, an alternative view could be that multiple branches may exact too 
large a metabolic demand on the axon, since they will all continue to grow until at least one finds 
a target. Once an axon is within a Schwann cell tube it not only receives some support from the 
glial cells, but it also has a much higher chance of finding a target that will provide trophic 
support, since the empty bands of Büngner are likely to lead to a distal target. In this scenario it 
would be advantageous to support a single growth cone until contact is made with empty 
Schwann cell tubes. Subsequent branching to fill adjacent empty tubes would be more likely to 
maximize the chances of finding an empty end target. 
 
Poor results are a common feature of facial nerve axotomy (334,335). In a simple repair of the 
main nerve abnormal movements, or synkinesis, of the various muscle groups supplied by the 5 
main terminal branches of the facial nerve are considered inevitable (336-338). It is thought that 
a major contributing factor to the synkinesis is the misdirection of axons (339,340) or their 
collaterals (202,304,341) into inappropriate final pathways resulting in polyneuronal innervation 
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(197,342,343). Guntinas-Lichius studied the effects of reducing collateral branching, on 
reinnervation of normally independent muscle groups innervated by separate terminal branches 
of the facial nerve (344). The number of collaterals at the point of repair was inhibited by 
antibodies to nerve growth factor, and the results analysed with retrograde labeling of each of the 
muscle groups. With a simple repair the total number of cell bodies labeled was greatly 
increased, which he assigns to 'hyperinnervation' by collaterals from previously unlabeled neural 
pools. In the antibody groups the number of cell bodies per muscle group is much more akin to 
the controls, albeit with some double- and triple-labeling. However, there is no change in the 
functional outcome between the repair and antibody-blocked groups.  
 
The YFP-H transgenic line offers an interesting tool with which to examine axonal regeneration. 
In the YFP-16, fully-labeled line images of regenerating nerves as they pass through the point of 
the repair become confused by the density of labeling. Whilst it is possible to trace out a wiring 
diagram in the normal control muscle, following an individual axon through this maelstrom is 
not feasible (252). The YFP-H line is sparsely labeled with only 5-10% of axons expressing the 
yellow fluorophore. Images of the site of a repair and the distal nerve provide a history of the 
route taken by a small number of regenerating axons. It provides a time-lapse snap-shot of the 
axons’ passage through the neuroma, and each of the subsequent branching points. Once the 
axon has made a connection with the distal muscle it can remodel its synaptic connections, but it 
cannot alter the path it took to get to the target. These tools show that individual axons respond 
very differently to the challenge of reinnervation.  
 
Most axons form searching loops at the point of the repair. The fixing process and the 
subsequent flattening as the nerves have been mounted on slides prevents us from commenting 
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on the direction of those loops and whether they are all in the same direction (i.e. right or left 
spirals). Individual axons might perform multiple or single loops, a very small number navigate 
across the repair site directly. Some, but not all, of the axons in the distal tubes do undergo 
branching. The degree of branching is very variable. Some axons produce no branches, others 
divide once or twice, and a few produce in excess of ten. Most branches remain in a single 
terminal nerve, however some enter different terminal nerves (Fig 48). This is direct evidence for 
the presence of synkinesis where a single axon innervates multiple muscles. In a mixed nerve it 
is possible for the distal targets to be trophically different (eg cutaneous sensory versus motor). 
This allows for remodeling to correct for aberrant wiring, provided an axon reaches both targets. 
An axon that only reaches appropriate targets would not have the differential signaling required 
to remodel its connections (296,345,346). The facial nerve is almost exclusively motor, 
supplying multiple muscle targets. Axons that reach more than one motor target would receive 
appropriate trophic support from all targets and therefore no impetus to undergo remodeling.  
 
There is some branching between proximal and distal ends of the normal terminal nerve to 
interscutularis which represents a 19.7% increase in the number of axons. This is greater than 
that found by Lu. This difference may result from a methodological disparity in the location of 
the proximal sample between the two studies. We have sampled the entire length of the terminal 
nerve, whilst he stopped 5mm from the muscle edge. There is less branching seen in the terminal 
nerve in YFP-H specimens than in the YFP-16 controls. In the YFP-H specimens the percentage 
of axons that express fluorophore increases with age.  We have seen in our specimens that there 
is a gradation of intensity of expression across axons (Fig 64). It has been suggested that the 
intensity may be related to the size of the axon or to accumulation of fluorescent protein over 
time (personal correspondence with JWL). Lu has demonstrated that larger axons have larger 
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motor units (252). This may explain the larger motor unit sizes seen in YFP-H controls versus 
YFP-16 controls. The reduced levels of branching seen in the YFP-H animals may reflect less 
actual branching, or less branching in this subset of axons with larger motor units. Where an 
axon has branched its terminal arbors tend to avoid overlap (347). Though the muscle 
preparations have been flattened in the Z plane, this relationship is largely preserved in the 
interscutularis, since it is a flat muscle in vivo. In the arbors of the normal YFP-H control 
specimens the axons tend not to overlap, suggesting that they are individual axons rather than 
branches that occurred proximal to the terminal nerve. In the intervention groups this is no longer 
the case. This supports the case that not all regenerating axons are individuals, some are sub-
branches that will tolerate overlapping arbors (Fig 65). 
 
The percentage change in the number of axons (i.e. branching) that occurs in the terminal nerve 
is not significantly greater in the intervention groups than in controls. However the total number 
of axons is significantly greater in both intervention groups, proximally and distally, than in 
controls. This suggests that either many more axons are being diverted into this terminal nerve, 
or that these axons have already branched several times prior to entering the terminal nerve. The 
percentage change in the neve repair group reduces over time until, by twelve weeks, it is less 
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Figure 64. Confocal microscope montage illustrating the gradation in intensity across a YFP-H arbor 
 
This is a double-labeled image of a YFP-H control specimen. Six axons are labeled with fluorophore, one of which is brighter than the rest. It is 
possible to elucidate the entire motor unit of this axon from the weaker signal of the remaining axons. 
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Figure 65. Confocal microscope montage illustrating overlapping arbors after reinnervation 
 
This is a double-labeled image of a YFP-H nerve graft specimen that has reinnervated its arbor. 
In comparison with the spaced motor units of the individual axons in the YFP-H control 
specimen (Fig 66), these axons are overlapping. 
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than in control specimens. This is primarily as a result of a reduction in the number of distal 
axons, indicating that sub-branches have been remodeled. This change does not occur in the 
nerve grafted group where the percentage change remains constant throughout. The process of 
axon remodeling in the nerve repair group is not occurring in the nerve graft group. 
 
The trend observed in the nerve repair group pattern is consistent with the literature whereby 
regenerating peripheral axons undergo an initial period of branching, with subsequent pruning of 
redundant axons and branches over time. In the 1950s Shawe performed an elegant series of 
experiments to try and elucidate and quantify this phenomenon (304). Earlier reports had 
suggested each original axon produced something between three and fifty or more new fibres 
(106,302,303,348). Shawe examined regenerating nerves in a rabbit model, by taking multiple 
sections above and below the site of nerve injury (crush or repair). These were stained by two 
different methods, and he accepts that there was only an 81% concordance between them, with 
particular difficulty in identifying fibres less than 0.5µm accurately. He performed a nerve crush 
or a nerve repair on two nerves: the mixed motor and sensory nerve to medial gastrocnemius, 
and the purely sensory sural nerve. After the crush injury in the mixed nerve, Shawe noted a 
rapid increase in the number of fibres around the site of injury, which extended both proximally 
and distally. Counts at the site of the crush indicate that each original axon gave rise to 3 
branches by day twenty five post injury. Of these only two thirds grew 1 cm by day fifty, giving 
a fibre count of double the original (the maximum achieved). This then reduced over the next 
fifty days, and then remained stable at 140% of the original until two hundred and twenty five 
days, when the experiment ceased. Myelination of fibres took longer, but by one hundred days, 
80% of the fibres were encased (still greater than 100% of the original number). The figures with 
the repaired nerve were very similar with the only difference being a greater increase in the 
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number of fibres initially seen proximal to the lesion. Shawe suggested this was aberrant 
recurrent growth. In the sural (sensory) nerve crush Shawe found a slightly different picture with 
slower initial growth and fewer branches. By thirty five days post injury there was a 37% 
increase in fibre numbers, suggesting that approximately 20% of original fibres had formed 
branches, roughly equivalent to the number of large, myelinated fibres in the original nerve. 
Shawe suggests that branching may be dependent on the size of the fibre, with large axons being 
capable of supporting more divisions, and that there may be a difference between sensory and 
motor neurons (304). 
 
This work exposes a contradiction in nerve regeneration theories. Shawe’s work, and that of Jenq 
and Coggeshall after him, suggest that there should be more fibres distal to a site of nerve injury, 
whether it is a crush or a repaired division (349). In contrast groups such as Chor, Gutman and 
Sanders proposed that approximately a third of axons will escape the site of a repair, and become 
a neuroma instead of entering the distal bands of Büngner (203,350). More recently Mackinnon 
performed experiments to follow the distal progress of sciatic nerves regenerating after nerve 
repair in a rat model over one to twenty four months (351). Repaired nerves were harvested and 
sectioned at the repair site and 1cm proximal and distal. Axon fibres were counted and their 
diameters estimated by taking the smallest diameter for each fibre in each section. The axon 
numbers increased significantly in comparison to controls in the months following repair, almost 
doubling in number at three months. This figure steadily fell, but remained significantly greater 
than controls at one year. By two years there was no longer a statistical difference between 
repaired and control nerves. In contrast the change in mean axon diameter (4.7µm) remained 
significantly less than controls (6.5µm) across the entire time frame, and did not change at all 
between one and two years . Mackinnon suggests that the number of axons only returned to a 
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stable state after two years, by which time the numbers were not significantly different from 
controls. The reduction in axon fibres to a non-significant level only occurred after a delay of a 
year. Mackinnon hypothesizes that this is due to pruning back of fibres that were unsuccessful in 
innervating a target connection. It is not clear why this process would take a year. This late 
reduction could also reflect age related loss as opposed to remodeling. Valdez has shown that in 
the absence of nerve injury, the number of myelinated motor axons can fall by 30% over an 
equivalent time frame of two years (5).  
 
It has been noted that in partial denervation a muscle recovers almost complete pre-injury tension 
after a few weeks, even if there is no regeneration of the severed axons (352-354). What is 
fascinating is that there appears to be no loss of muscle fibres in this process (355,356). The 
denervated muscle fibres are reinnervated by sprouts from the remaining axons, either through 
nodal or terminal sprouting (357-361). Nodal sprouts are branches that occur at a node of 
Ranvier, where an axonal offshoot follows an empty perineural sheath to an unoccupied junction. 
Terminal sprouts originate from axons at neuromuscular junctions, and re-occupy the empty 
gutter of a denervated adjacent junction. 
 
Burkel has shown that several myelinated axons can reside in a single perineural sheath with no 
intervening septa (362). Although there is a basement membrane surrounding Schwann cells, this 
leaves open the possibility of communication between axons at nodes of Ranvier in a common 
perineural sheath. These nodal sprouts only occur at nodes that are in proximity of a branch point 
in an adjacent denervated sheath (361). The sprouts seem to occur at the node closest to the 
empty branch point. It has been suggested that nodal sprouting only occurs intramuscularly 
(357). Hoffman reported that he saw fine processes extramuscularly, but Brown thinks that these 
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were elements from denervated Schwann cells (343,363). In this study it is hard to establish the 
presence of nodal sprouting intramuscularly, but there is evidence for branching occurring at 
extramuscular nodes and multiple sub-branches existing within a single myelin sheath (Figs 50 
& 45). Strictly speaking this is classified as branching, as it is occurring outside of the muscle 
but the process looks very similar. Interestingly this is occurring far from the empty end plates 
and may indicate that there is a branching stimulus coming from the empty Schwann cell tubes.  
 
Terminal sprouts emanate from occupied neuromuscular junctions. Their paths across the surface 
of muscle fibres are erratic and resemble 'escaped' axons, outside of the directed growth 
exhibited by regenerating axons or nodal sprouts within the confines of a perineural or Schwann 
cell tube (203). Schwann cell processes probably accompany these terminal sprouts as they grow 
towards vacant end-plates (364). In my results there is some evidence of terminal sprouting, 
though it is not as prevalent as extramuscular branching (Fig 59). Both nodal and terminal 
sprouts mature and eventually myelinate (343,359). There is a watershed diameter of between 1 
and 2 µm at which all axons become myelinated  (209). My immunohistochemical data shows 
that all the axons in this study were encased in myelin sheaths, and that there are instances of 
myelin sheaths that are unoccupied. There are a number of examples where there are several 
axons within a single myelin sheath (Fig 45). This evidence is supported by a few specimens 
where the autofluorescence of the connective tissue demonstrates the Büngner’s bands, and the 
several axons are visible in a single tube. The resolution of the immunohistochemical labeling is 
not fine enough to determine whether the axons are individually ensheathed within this outer 
layer. If not this arrangement would be detrimental to the propagation of an action potential in 
any single axon.  
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8.2 Thresholding of Axon Populations 
In this study we have shown that the population of axons that reinnervates a muscle after nerve 
repair or nerve graft is different from controls. Axon calibres fluctuate and can vary considerably 
along their length especially where they are pinched at the nodes of Ranvier. Overall they tend to 
taper more distally. Our method of tracing axons for 5 digital slices (1.9µm) provides both a total 
axonal count and accurate mean diameters. In addition, by being able to scroll through a digital 
cross section over several hundred cross sections (even though only 5 are traced and averaged), 
avoids two possible sampling errors: mistaking an aberrant axonal outline for a branch point and 
sampling through a node (Fig 50).  
 
Axons in control nerves are relatively homogeneous in size, with an average diameter of 8.0µm. 
The diameters of axons in the both the intervention groups are much more heterogeneous. They 
are characterised by a few larger axons, with a similar calibre to those in the normal controls, and 
numerous smaller fibres with a diameter less than 2.5µm. This population of very small axons is 
initially predominant in both groups, with the histogram of axon diameters skewed to the left. In 
both groups the number of larger fibres increases over time and the population of small fibres 
dwindles but never disappears. The mean axon diameters remain significantly smaller than the 
controls, with the repairs being slightly larger than the grafts throughout. We know that 
remodeling of axons occurs after successful reoccupation of motor end plates, with those axons 
unable to establish connections retracting (197). The increase in axon diameter probably 
indicates the growth of the successful axons that are receiving trophic support from their motor 
unit. Lu has shown that the diameter of an axon does correlate with the size of its motor unit 
(252). Measuring the diameters of axon branches at a site of division in YFP-H animals shows 
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that there can be considerable variation in size. All branches are smaller than the original axon 
but not all branches are of equal size (Fig 47).  
 
Bray's study of regenerating, unmyelinated fibres in the crushed cervical sympathetic trunk, 
showed some similarities to our study (301). Distal to the injury there was a four-fold increase in 
axon number at one month post injury, and each Schwann cell tube contained many small axons. 
At one month the median axon diameter was less than 0.4µm and this left shift was persistent at 
six months, despite a small number of the axons increasing in size to near normal, and the 
proportion of axons greater than 0.9µm increasing from 1% to 10%. This supports the idea of an 
initial period of intense sprouting, which produces very small calibre fibres that are subsequently 
remodeled, with those that presumably don't reach distal targets atrophying, and those that do 
increasing in diameter. This may help to explain Jacobs’s results, where a series of cross facial 
nerve grafts were biopsied at their distal extent six months after the first stage of a reanimation 
procedure (at the time of the second stage) (81). He found large numbers of small unmyelinated 
axons, but relatively few larger myelinated axons at the distal end of the nerve graft. Without a 
distal muscle target the regenerating axons would have no trophic stimulus to mature and 
remodel the multiple branches. Without this process of remodeling it is impossible to be certain 
how many of these fibres represent individual axons. My results confirm this increase in axon 
numbers distal to the site of intervention, with multiple very small axons and fewer axons of a 
diameter equivalent to controls. Subsequent remodeling over time with pruning of the number of 
axons is observed in the nerve repair group. This is most apparent in the change in distal axon 
numbers. In the nerve repair group a trend is noticeable between four and six weeks and the 
percentage change continues to fall between six and twelve weeks. This trend is not apparent in 
the nerve graft group. There is no fall in distal axon numbers over time and the percentage 
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change in axon numbers remains stable from four to twelve weeks. This suggests that the second 
repair site encountered by regenerating axons in the grafted group has an impact on their ability 
to reinnervate the muscle, and that the process of remodeling is either slower or not occurring in 
this group. 
 
As each axon produces successful sub-branches that innervate vacant end plates, its motor unit 
size increases. Regardless of the initial size of an axon’s motor unit, there seems to be a 
maximum amount it can increase in size, of four to five-fold (365-367). Unfortunately our data 
doesn’t allow us to know how many of the axons at the proximal sampling point are already 
branches themselves. This prevents us from calculating an accurate mean motor unit size from 
this data alone. In both interventional groups the number of axons at the proximal sample point is 
greater than the control specimens at all time points. Over time the change in axon numbers with 
remodeling is reflected in the motor unit sizes. The motor unit size in nerve repairs trends toward 
that of controls, whilst in the nerve grafted group it remains static. However both are consistently 
smaller. At face value this suggests that the motor units are smaller after intervention, and that 
each axon now innervates fewer muscle fibres than in controls. This is not impossible, as some 
axons that would ordinarily have innervated other muscles, may now be included in the branch to 
interscutularis. However it is unlikely that the branch to interscutularis would consistently have 
significantly more axons in it than before. In addition, the loss of the homogeneity in axon 
diameter seen in the control group suggests that not all the axons in the intervention groups are 
the same.  
 
We re-evaluated the data using diameter as a proxy measure, to indicate which axons were true 
axons and which were branches.  The mean diameter of the axons in the control groups is 8.0µm. 
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Lu has shown that the interscutularis is only innervated by motor axons so this population of 
axons can be used to define a typical motor axons (252). Two standard deviations from this value 
gives a diameter range of 5.5µm to 10.5µm (mean 8.6µm). We used the smaller value as a cut 
off, assuming that axons smaller than this value were unlikely to be making a significant 
contribution to muscle contraction, and were most likely to be either motor axon sub-branches 
undergoing remodeling, or sensory axons that had been misdirected into the terminal nerve. This 
thresholded data exposed changes in the trends seen in axon remodeling. 
 
Thresholding of the control data excluded 23 of 278 axons that were smaller than 2 standard 
deviations. These axons ranged from 3.01µm to 5.41µm. The difference in the intervention 
groups is much more dramatic, but brought the distribution of axon diameters into line with the 
control group. After thresholding there is no significant difference in the overall axon diameter 
distribution between the groups. The change in axon diameter over time is more subtle, though 
there is still a disparity between the two groups. The nerve repair group steadily increases in 
mean diameter from 7.3µm at four weeks, to 7.5µm at six weeks, and 8.1µm by twelve weeks. 
This compares with a control mean both before (8.0µm) and after thresholding (8.6µm). The 
nerve graft group increases from 7.0µm at four weeks, to 7.4µm at six weeks, and 7.6µm at 
twelve weeks. It is possible that this represents a delay in the time it takes the graft group to 
remodel, which would fit with the anatomical reality of two repair sites, and a devascularised 
segment of graft tissue. 
 
Given that ninety percent of nerve repairs leave a deficit, it seems unlikely that the motor units 
would be smaller after nerve repair or nerve graft (368). The number of thresholded axons at the 
proximal point increases over time in both interventional groups. This would be consistent with a 
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gradual increase in diameter of some smaller axons (that are initially filtered out by 
thresholding), as they take over the territories of less successful smaller sub-branches, and get 
more of a foothold in the reinnervated muscle (298,311-315). The mean motor unit was re-
calculated using only thresholded axons. In contrast to the unfiltered results, these motor unit 
sizes are significantly larger than controls (P=0.0002, One-way ANOVA). This is more 
consistent with Ashur’s estimate of approximately 40% of axons crossing a neurorraphy. They 
get smaller over time which is consistent with remodeling where successful axons get larger and 
unsuccessful axon branches are pruned (310). Using thresholded data the size of the mean motor 
unit twelve weeks after intervention was significantly larger in both nerve repairs (18.0 ± 5.7) 
and nerve grafts (22.7 ± 3.2) compared to controls [14.0 ± 2.5 (P<0.0001, One-way ANOVA)]. 
 
Individual axons have been shown to be capable of increasing the number of muscle fibres they 
innervate, and hence their motor unit size, in response to partial denervation (221,222). However, 
their capacity to increase their influence is not limitless. A four to six fold increase in motor unit 
size is unsustainable, and tetanic force cannot be maintained. In our experimental model this 
degree of increase is not seen, but this model uses a small muscle and its original nerve. In facial 
reanimation a small buccal branch is used to power a large skeletal muscle. It is much more 
likely that the donor nerve will be over-stretched. Unfortunately there is very little data in the 
literature regarding the axon counts in humans, in either the donor nerves or muscles used in 
facial reanimation. Jacobs suggested that the buccal branch contains approximately 5500 axons 
of which 1700 are myelinated (81). Happak peformed an elegant study looking at the muscle 
fibres in a variety of facial muscles, but unfortunately did not investigate the axonal loads of 
their innervating nerves (369). Our unit is currently revisiting the subject to elucidate this matter 
more clearly. If the donor nerve is over stretched it is the bottleneck, the rate-limiting factor 
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affecting outcomes. This suggests that we should turn the focus of our reconstructive planning 
towards the donor nerve, trying to tailor the muscle transfer to its re-innervating capacity. A 
smaller muscle that is well innervated would be more physiologically sound than a larger, poorly 
innervated one. 
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9. Conclusion 
 
We can conclude that both the first and second null hypotheses are upheld with respect to the 
neuromuscular junctions. There is no difference in the number of neuromuscular junctions 
between either the repairs or grafts and the control populations. After reinnervation individual 
junctions, and the total receptor surface area, are smaller than controls, regardless of whether the 
nerves were repaired or grafted. The reinnervated junctions after nerve graft are also smaller than 
those after nerve repair, but in both groups they reached an adequate size to be consistent with 
normal function (299). There is no difference in the neuromuscular junction characteristics 
between the control group and either the nerve repair of nerve graft group. 
 
The picture with respect to the regenerating axons is more complicated. At first glance it would 
seem that the first null hypothesis is rejected whilst the second is upheld. There are more axons 
in the reinnervated specimens than in controls, but there is no difference between the repaired or 
grafted nerves. However, the regenerating axons are a heterogeneous and evolving population of 
axons. Whilst the regenerating axons from the nerve graft group remain significantly different 
from the controls over time, the nerve repair group start to resemble the controls. However, the 
difference between the repair and grafts never becomes significant. The first null hypothesis can 
be rejected in part (i.e. there is a difference between grafts and controls) but the second is 
retained. 
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When analyzing for both intervention and time with respect to motor unit size the first null 
hypothesis is retained. However, looking at intervention alone it is rejected  (the motor units 
were significantly smaller in the intervention groups than controls), whilst the second is retained 
(there was no difference between nerve repairs and nerve grafts). However, closer examination 
of the regenerating axons shows large numbers of very small fibres and fewer large axons that 
resemble the homogenous control samples. Once the axon populations are controlled for calibre 
the picture changes. The first null hypothesis is retained, as the axon populations in the nerve 
repair and nerve graft group are remodeled to more closely resemble the controls. However, 
there is significant difference between the two intervention groups, rejecting the second null 
hypothesis. 
 
The use of transgenic mice that express yellow fluorescent protein in their axons has provided us 
with an extraordinary tool with which to examine the entire wiring system of a muscle after 
nerve repair and nerve graft. This has pertinent clinical relevance by increasing our 
understanding of how this interaction is affected. The medical profession accepts that we rarely 
manage to return an injured body to its pre-injured state, but through greater understanding we 
reduce the size of the deficit. Our dealings with the nervous system are still in their infancy, and 
currently we often have to accept poorer outcomes than we are comfortable with. The advent of 
microsurgery has changed radically how we intervene in nerve injuries, but there is still room for 
improvement. As we understand more we can adapt our techniques to strive for improvements 
whilst, or perhaps by, embracing our limitations. 
In the scenarios we are concerned with in this thesis, the biology seems to be trying to overcome 
the obstacles in its path by expanding the influence of each axon, in an attempt to fill the empty 
arbor in the muscle. The nerve is thus the bottleneck and the reduced number of axons re-
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innervating the muscle leads to changes in the proportions of the motor units that cannot be 
subsequently remodeled. There is however a limit to that expansion. Perhaps we would be better 
off matching the muscular arbor to the capabilities of the donor nerve, using a smaller muscle 
that can be more efficiently reinnervated. In addition the branching of the regenerating axons 
into terminal nerves that lead to different target muscles means that synkinesis is almost 
inevitable. This aberrant wiring is beyond the ability of biological remodeling to correct. The 
changes at the neuromuscular junction, stable over all time frames, perhaps indicate that 
complete denervation prematurely ages the muscle. This is a problem to which we have no 
solution at present, other than the encouraging work in the field of ageing that suggests that some 
of this change could be reversible with calorific restriction or exercise (5). 
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